Lighting Science (LSCG) Inactive 10-Q14 Nov 132013 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2013	Nov. 11, 2013
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'LIGHTING SCIENCE GROUP CORP	'
Entity Central Index Key	'0000866970	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	208,149,519

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:	'	'
Cash and cash equivalents	$10,292,524	$15,834,077
Restricted cash	5,000,000	5,000,000
Accounts receivable, net	9,975,784	13,130,387
Inventories, net	26,762,893	28,981,444
Prepaid expenses	1,582,325	2,457,033
Other current assets	505,884	683,842
Total current assets	54,119,410	66,086,783
Property and equipment, net	10,107,421	16,543,113
Intangible assets, net	1,609,951	864,410
Pegasus Commitment	1,600,000	1,360,000
Other long-term assets	366,271	739,480
Total assets	67,803,053	85,593,786
Current liabilities:	'	'
Lines of credit	30,511,550	1,501,724
Current portion of long-term debt	4,872	4,087
Accounts payable	10,369,281	14,791,213
Provision for losses on non-cancelable purchase commitments	2,255,056	5,678,992
Accrued expenses	4,703,857	6,754,946
Total current liabilities	47,844,616	28,730,962
Long-term debt, less current portion	9,870	14,321
Total other liabilities	11,949,822	9,335,026
Total liabilities	59,794,438	38,065,988
Redeemable Convertible Preferred Stock	386,813,176	352,025,176
Commitments and contingencies	'	'
Stockholders' deficit:	'	'
Preferred stock, $.001 par value, authorized 25,000,000 shares, 113,643 shares of Series H, 62,365 shares of Series I and 17,394 shares of Series J issued and outstanding as of September 30, 2013 and 113,643 shares of Series H, 62,365 shares of Series I and 0 of Series J issued and outstanding as of December 31, 2012	'	'
Common stock, $.001 par value, authorized 475,000,000 shares, 210,649,318 and 208,063,486 shares issued as of September 30, 2013 and December 31, 2012, respectively, 208,144,318 and 205,558,486 shares outstanding as of September 30, 2013 and December 31, 2012, respectively	210,649	208,063
Additional paid-in capital	331,202,703	347,686,258
Accumulated deficit	-702,635,603	-644,916,568
Accumulated other comprehensive loss	-3,824,810	-3,717,631
Treasury stock, 2,505,000 shares as of September 30, 2013 and December 31, 2012, at cost	-3,757,500	-3,757,500
Total stockholders' deficit	-378,804,561	-304,497,378
Total liabilities and stockholders' deficit	67,803,053	85,593,786
Riverwood Warrants [Member]	'	'
Current liabilities:	'	'
Warrants liability	6,639,952	7,960,705
September 2012 Warrants [Member]	'	'
Current liabilities:	'	'
Warrants liability	1,600,000	1,360,000
Pegasus Warrant [Member]	'	'
Current liabilities:	'	'
Warrants liability	3,700,000	'
Series H Redeemable Convertible Preferred Stock [Member]	'	'
Current liabilities:	'	'
Redeemable Convertible Preferred Stock	227,288,549	227,288,549
Series I Redeemable Convertible Preferred Stock [Member]	'	'
Current liabilities:	'	'
Redeemable Convertible Preferred Stock	124,736,627	124,736,627
Series J Redeemable Convertible Preferred Stock [Member]	'	'
Current liabilities:	'	'
Redeemable Convertible Preferred Stock	$34,788,000	'

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
	Sep. 30, 2013	Dec. 31, 2012	Series H Redeemable Convertible Preferred Stock [Member]	Series H Redeemable Convertible Preferred Stock [Member]	Series I Redeemable Convertible Preferred Stock [Member]	Series I Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]
Preferred stock, par value	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Preferred stock, shares authorized	25,000,000	25,000,000	135,000	135,000	90,000	90,000	50,000	50,000
Preferred stock, shares issued	'	'	113,643	113,643	62,365	62,365	17,394	0
Preferred stock, shares outstanding	'	'	113,643	113,643	62,365	62,365	17,394	0
Preferred stock, shares issued	'	'	113,643	113,643	62,365	62,365	17,394	0
Preferred stock, shares outstanding	'	'	113,643	113,643	62,365	62,365	17,394	0
Common stock, par value	$0.00	$0.00	'	'	'	'	'	'
Common stock, shares authorized	475,000,000	475,000,000	'	'	'	'	'	'
Common stock shares issued	210,649,318	208,063,486	'	'	'	'	'	'
Common stock, shares outstanding	208,144,318	205,558,486	'	'	'	'	'	'
Treasury stock, shares	2,505,000	2,505,000	'	'	'	'	'	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue	$21,951,094	$32,056,779	$61,925,643	$101,069,211
Cost of goods sold	27,261,065	32,532,210	64,973,577	117,889,925
Gross deficit	-5,309,971	-475,431	-3,047,934	-16,820,714
Operating expense:	'	'	'	'
Selling, distribution and administrative	11,749,901	15,652,102	38,171,922	45,297,615
Research and development	2,630,137	2,485,983	7,774,273	7,371,527
Restructuring expense	55,275	3,908,562	184,107	5,759,814
Impairment of goodwill and other long-lived assets	'	379,537	'	379,537
Depreciation and amortization	2,594,396	2,245,665	6,886,110	6,564,516
Total operating expenses	17,029,709	24,671,849	53,016,412	65,373,009
Loss from operations	-22,339,680	-25,147,280	-56,064,346	-82,193,723
Other (expense) income:	'	'	'	'
Interest income	1,315	789	3,643	5,112
Interest expense	-1,097,141	-1,181,890	-2,943,723	-3,758,854
Related party interest expense	'	'	'	-250,000
(Increase) decrease in fair value of liabilities under derivative contracts	-2,116,824	2,352,026	1,320,753	2,713,876
Dividends on preferred stock	'	'	'	-1,799,392
Accretion of preferred stock	'	'	'	-7,523,459
Other income (expense), net	49,203	-19,151	-35,362	-142,838
Total other (expense) income	-3,163,447	1,151,774	-1,654,689	-10,755,555
Loss before income tax expense	-25,503,127	-23,995,506	-57,719,035	-92,949,278
Income tax expense	'	'	'	'
Net loss	-25,503,127	-23,995,506	-57,719,035	-92,949,278
Foreign currency translation (loss) gain	130,601	-51,530	-107,179	104,884
Comprehensive loss	-25,372,526	-24,047,036	-57,826,214	-92,844,394
Controlling Shareholders [Member]	'	'	'	'
Other (expense) income:	'	'	'	'
Dividends on preferred stock	'	'	'	12,488,175
Basic and diluted net loss per weighted average common share	($0.30)	($0.37)	($0.46)	($1.36)
Basic and diluted weighted average number of common shares outstanding	170,672,339	170,560,715	170,645,985	171,573,632
Noncontrolling Shareholders [Member]	'	'	'	'
Other (expense) income:	'	'	'	'
Dividends on preferred stock	'	'	'	($12,488,175)
Basic and diluted net loss per weighted average common share	($0.30)	($0.37)	($0.46)	($1.81)
Basic and diluted weighted average number of common shares outstanding	35,062,174	34,171,729	34,996,177	33,301,911

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Inventory valuation allowance	$5,100,000	$3,100,000	$5,697,809	$15,435,121
Provisions for losses on noncancelable purchase commitments	1,900,000	785,000	1,900,000	3,400,000
Selling, Distribution and Administrative Expenses [Member]	'	'	'	'
Related party expense	$656,000	$461,000	$1,800,000	$1,200,000

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Stockholders' Deficit (USD $)	Total	Series H Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]
	Total	Series H Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Series H Redeemable Convertible Preferred Stock [Member]	Series J Redeemable Convertible Preferred Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]
Balance at Dec. 31, 2012	($304,497,378)	'	'	$208,063	$347,686,258	'	'	($644,916,568)	($3,717,631)	($3,757,500)
Balance, shares at Dec. 31, 2012	'	'	'	208,063,486	'	'	'	'	'	'
Issuance of restricted stock and options for directors' compensation	259,724	'	'	1,813	257,911	'	'	'	'	'
Issuance of common stock for directors' compensation, shares	'	'	'	1,813,411	'	'	'	'	'	'
Stock based compensation expense	4,850,527	'	'	'	4,850,527	'	'	'	'	'
Stock issued under equity compensation plans	35,913	'	'	773	35,140	'	'	'	'	'
Stock issued under equity compensation plans, shares	'	'	'	772,421	'	'	'	'	'	'
Warrant issued to a customer	22,916	'	'	'	22,916	'	'	'	'	'
Placement agent commissions on issuance of Series H Redeemable Convertible Preferred Stock	'	-60,000	'	'	'	-60,000	'	'	'	'
Deemed dividends on Series J Redeemable Convertible Preferred Stock	'	'	-21,590,049	'	'	'	-21,590,049	'	'	'
Net loss	-57,719,035	'	'	'	'	'	'	-57,719,035	'	'
Foreign currency translation adjustment	-107,179	'	'	'	'	'	'	'	-107,179	'
Balance at Sep. 30, 2013	($378,804,561)	'	'	$210,649	$331,202,703	'	'	($702,635,603)	($3,824,810)	($3,757,500)
Balance, shares at Sep. 30, 2013	'	'	'	210,649,318	'	'	'	'	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
Condensed Consolidated Statements of Cash Flows (USD $)	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:	'	'
Net loss	($57,719,035)	($92,949,278)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	6,886,110	6,564,516
Impairment of goodwill and other long-lived assets	'	379,537
Impairment of plant and equipment	1,328	1,693,779
Issuance of restricted stock and stock options for directors' compensation	259,724	956,916
Stock based compensation expense	4,850,527	4,603,988
Accretion of preferred stock redemption value	'	7,523,459
Non-cash sales incentive	22,916	458,162
Allowance for doubtful accounts receivable	130,438	181,003
Inventory valuation allowance	5,697,809	15,435,121
Provision for losses on non-cancelable purchase commitments	1,908,694	3,399,490
Decrease in fair value of warrants	-1,320,753	-2,713,876
Dividends on preferred stock	'	1,799,392
Loss (gain) on disposal of assets	497,140	-22,181
Changes in operating assets and liabilities:	'	'
Accounts receivable	2,998,530	12,114,955
Inventories	-8,262,220	-9,479,797
Prepaid expenses	873,962	6,447,594
Other current and long-term assets	551,167	409,852
Accounts payable	-4,530,892	-9,022,436
Accrued expenses and other liabilities	-2,625,304	2,816,346
Unearned revenue	'	-39,278
Net cash used in operating activities	-49,779,859	-49,442,736
Cash flows from investing activities:	'	'
Purchases of property and equipment	-1,486,067	-5,140,226
Capitalized patents	-772,322	-315,625
Proceeds from sale of property and equipment	565,918	36,000
Net cash used in investing activities	-1,692,471	-5,419,851
Cash flows from financing activities:	'	'
Net proceeds from draws on lines of credit and other short-term borrowings	29,009,826	-20,518,032
Payment of short and long-term debt	-3,666	-10,276
Proceeds from issuance of common stock under equity compensation plans	35,913	876,743
Redemption of 6% Convertible Preferred Stock	'	-33,830
Payment in settlement of Repurchase Obligation	'	-10,245,675
Placement agent commissions on private placements	-556,049	-7,620,413
Net cash provided by financing activities	45,880,024	72,267,517
Effect of exchange rate changes on cash	50,753	58,524
Net (decrease) increase in cash	-5,541,553	17,463,454
Cash and cash equivalents balance at beginning of period	15,834,077	3,071,673
Cash and cash equivalents balance at end of period	10,292,524	20,535,127
Supplemental disclosures:	'	'
Interest paid during the period	2,878,583	4,011,549
Non-cash investing and financing activities:	'	'
Issuance of Repurchase Obligation	'	12,100,000
Change in fair value of Repurchase Obligation	'	388,175
Settlement of Repurchase Obligation with issuance of Series I Redeemable Convertible Preferred Stock	'	-6,000,000
Treasury stock received in settlement of Repurchase Obligation	'	3,757,500
Deemed dividends on Series H, I and J Redeemable Convertible Preferred Stock	-21,590,049	-202,105,466
Note receivable for Issuance of Series H Redeemable Convertible Preferred Stock	'	24,500,000
Pegasus Commitment	'	-1,600,000
Series G Preferred Units [Member]	'	'
Cash flows from financing activities:	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	18,250,000
Series H Redeemable Convertible Preferred Stock [Member]	'	'
Cash flows from financing activities:	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	85,205,000
Series I Redeemable Convertible Preferred Stock [Member]	'	'
Cash flows from financing activities:	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	'	6,364,000
Series J Redeemable Convertible Preferred Stock [Member]	'	'
Cash flows from financing activities:	'	'
Proceeds from issuance of Preferred Units / Redeemable Convertible Preferred Stock	$17,394,000	'

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Cash Flows (Parenthetical)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Statement Of Cash Flows [Abstract]	'	'
Convertible Preferred stock dividend rate	6.00%	6.00%

Description_of_Business_and_Ba

Description of Business and Basis of Presentation	9 Months Ended
Description of Business and Basis of Presentation	Sep. 30, 2013
Accounting Policies [Abstract]	'
Description of Business and Basis of Presentation	'
	NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
	Overview
	Lighting Science Group Corporation (the “Company”) was incorporated in Delaware in 1988 and designs, develops, manufactures and markets general illumination products that exclusively use light emitting diodes (“LEDs”) as their light source. The Company’s product portfolio includes LED-based retrofit lamps (replacement bulbs) that can be used in existing light fixtures and sockets as well as purpose built LED-based luminaires (light fixtures), for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. The Company assembles and manufactures products internally and through its contract manufacturers in China and India.
	Basis of Financial Statement Presentation
	The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2012 is derived from the Company’s audited financial statements. Operating results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2013. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2012 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2013.
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying consolidated financial statements.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Use of Estimates

	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.

	Accounts Receivable

	The Company records accounts receivable at the invoiced amount when its products are shipped to customers or upon the completion of specific milestone billing requirements. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based upon age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of September 30, 2013 and December 31, 2012, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $396,000 and $1.2 million, respectively.

	As of September 30, 2013 and December 31, 2012, there were $8.2 million and $11.4 million, respectively, of eligible accounts receivable pledged as collateral for the Company’s line of credit with Wells Fargo Bank, N.A. (“Wells Fargo”).



	Revenue Recognition

	The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once such terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.

	The Company recognizes revenue on certain long-term, fixed price, custom lighting design projects using the percentage of completion method based on the ratio of costs incurred for each contract in a period to the estimated total costs to be incurred for each contract. Contract costs include all direct material, direct labor and other indirect costs related to contract performance. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, estimated profitability and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.

	For smaller or shorter term custom lighting design projects or projects where estimated total costs cannot be determined, revenue is recognized using the completed contract method where recognition occurs upon substantial completion and acceptance by the customer of the project. Amounts received as deposits against future completion of completed contract method projects are recorded as unearned revenue until such projects are completed and title passes to the customer.

	Product Warranties

	The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products and such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. Changes in the warranty liability for the nine months ended September 30, 2013 are as follows:




	Warranty provision as of December 31, 2012	$	2,108,012
	Additions to provision		1,977,142
	Less warranty costs		(2,653,091	)


	Warranty provision as of September 30, 2013	$	1,432,063

	Fair Value of Financial Instruments

	Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expense and other current liabilities are carried at amounts that approximate their fair value due to the short-term maturity of these instruments.

	The Riverwood Warrants, September 2012 Warrants and the Pegasus Commitment (each as defined in Note 9 below) and the Pegasus Warrant (defined in Note 8 below) were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period.

Liquidity_and_Capital_Resource

Liquidity and Capital Resources	9 Months Ended
Liquidity and Capital Resources	Sep. 30, 2013
Text Block [Abstract]	'
Liquidity and Capital Resources	'
	NOTE 3. LIQUIDITY AND CAPITAL RESOURCES

	As shown in the condensed consolidated financial statements, the Company has experienced significant net losses as well as negative cash flows from operations since its inception. The Company’s cash expenditures primarily relate to procurement of inventory, payment of salaries, employee benefits and other operating costs and purchases of production equipment and other capital investments. The Company’s primary sources of liquidity have historically been borrowings from Wells Fargo and sales of common stock and preferred stock to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings, LLC (“LSGC Holdings”), LSGC Holdings II, LLC (“Holdings II”) and PCA LSG Holdings, LLC (“PCA Holdings”), which together with its affiliates, is the Company’s controlling stockholder. However, as detailed below, the Series H and I Preferred Offering (defined in Note 9 below) was provided primarily by parties other than Pegasus Capital and its affiliates.

	As of September 30, 2013, the Company had cash and cash equivalents of $10.3 million and an additional $5.0 million in cash subject to restrictions pursuant to the Company’s asset-based revolving credit facility with Wells Fargo (the “Wells Fargo ABL”). The Wells Fargo ABL provides the Company with a borrowing capacity of up to $50.0 million, which capacity is equal to the sum of (i) 85% of its eligible accounts receivable plus up to $7.5 million of eligible inventory, less certain reserves established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) unrestricted cash held in a Wells Fargo deposit account (“Qualified Cash”), plus (iii) the amount of the Second Lien Letter of Credit Facility with Ares Capital Corporation (“Ares Capital”), pledged in favor of Wells Fargo (the “Ares Letter of Credit Facility”) for the benefit of the Company (collectively, the “Borrowing Base”). The Company is at all times required to maintain (i) a Borrowing Base that exceeds the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million in Qualified Cash. The Company would be required to comply with certain specified EBITDA requirements in the event that it has less than $2.0 million available for borrowing under the Wells Fargo ABL.

	On March 31, 2013, the Company entered into Amendment No. 6 (“Amendment No. 6”) to the Wells Fargo ABL, which among other things, (i) extended the maturity date of the Wells Fargo ABL to April 2, 2014, and (ii) reduced the maximum credit available under the Wells Fargo ABL by $2.5 million (from $50.0 million to $47.5 million) on November 22, 2013 if (x) the Company’s consolidated earnings (loss) before interest, tax, depreciation and amortization for the nine month period ending on September 30, 2013 is greater than $(20.2 million) and (y) excess availability under the Wells Fargo ABL on November 22, 2013 is less than $10.0 million. As of September 30, 2013, the Company had $30.5 million of outstanding borrowings under the Wells Fargo ABL and additional borrowing capacity of $14.1 million.

	On September 11, 2013, the Company issued an aggregate of 17,394 shares of its newly designated Series J Convertible Preferred Stock, par value $0.001 per share (the “Series J Preferred Stock”), at a price of $1,000 per share (the “Stated Value”) for aggregate proceeds of $17.4 million (the “Series J Preferred Offering”). The shares of Series J Preferred Stock were issued pursuant to a preferred stock subscription agreement (the “Series J Subscription Agreement”) entered into between the Company, RW LSG Holdings LLC, (“Riverwood Holdings”), an affiliate of Riverwood LSG Management Holdings LLC (“Riverwood Management”) and Riverwood Capital Partners L.P. (“Riverwood Capital,” and together with Riverwood Holdings, Riverwood Management and their affiliates, “Riverwood”), PCA Holdings and Holdings II. The Company issued 12,500, 2,500 and 2,394 shares of Series J Preferred Stock to Holdings II, PCA Holdings and Riverwood Holdings, respectively.

	In an effort to strengthen the balance sheet and provide liquidity to meet the Company’s cash flow needs for the next twelve months, the Company will seek additional sources of liquidity and continue to implement cost control measures. The Company may not have access to sources of liquidity in an amount or on terms that are acceptable to the Company. If the Company is unable to obtain sufficient capital when needed, the Company’s business, compliance with the credit facility and future prospects will be adversely affected.

Detail_of_Certain_Balance_Shee

Detail of Certain Balance Sheet Accounts	9 Months Ended
Detail of Certain Balance Sheet Accounts	Sep. 30, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Detail of Certain Balance Sheet Accounts	'
	NOTE 4. DETAIL OF CERTAIN BALANCE SHEET ACCOUNTS
	Inventories
	Inventories consisted of the following as of the dates indicated:


		September 30,			December 31,
		2013			2012

	Raw materials and components	$	14,135,586		$	15,150,768
	Work-in-process		1,856,235			1,309,447
	Finished goods		10,771,072			12,521,229


	Total inventory, net	$	26,762,893		$	28,981,444

	As of September 30, 2013 and December 31, 2012, inventories were stated net of inventory valuation allowances of $19.7 million and $25.6 million, respectively. The Company considered a number of factors in estimating the required inventory valuation allowances, including (i) the focus of the business on the next generation of the Company’s products, which utilize lower cost technologies, (ii) the strategic focus on core products to meet the demands of key customers and (iii) the expected demand for the Company’s current generation of products, which are approaching the end of their lifecycle upon the introduction of the next generation of products.

	Property and Equipment, Net
	Property and equipment, net consisted of the following as of the dates indicated:


		September 30,			December 31,
		2013			2012

	Leasehold improvements	$	1,541,850		$	1,627,933
	Office furniture and equipment		1,180,563			1,255,244
	Computer hardware and software		9,369,127			8,924,424
	Tooling, production and test equipment		18,225,025			19,194,959
	Construction-in-process		126,692			134,240

	Total property and equipment		30,443,257			31,136,800
	Accumulated depreciation		(20,335,836	)		(14,593,687	)


	Total property and equipment, net	$	10,107,421		$	16,543,113

	Depreciation related to property and equipment was $2.6 million and $2.2 million for the three months ended September 30, 2013 and 2012, respectively. Depreciation related to property and equipment was $6.9 million and $6.4 million for the nine months ended September 30, 2013 and 2012, respectively.
	Impairment of Property and Equipment
	Property and equipment are depreciated over their estimated economic lives. Long-lived assets, including property and equipment, are evaluated to determine whether, in management’s judgment, events or changes in circumstances have occurred that may warrant a revision of the estimated useful life or whether the remaining balance should be evaluated for possible impairment. Such impairment tests compare estimated undiscounted cash flows over the remaining life of the property and equipment in assessing whether an asset has been impaired. If an impairment is indicated, the asset is written down to its fair value based on an estimate of its discounted cash flows.
	The Company performed an impairment analysis of property and equipment related to its wholly-owned subsidiary, Lighting Science Group Mexico S. de R.L. de C.V. (“LSG Mexico”) in September 2012 due to the announced commitment by the Company’s Board of Directors to transition all manufacturing in Mexico to Jabil Circuit, Inc., the Company’s contract manufacturer in Mexico (the “Mexico Closing”). This review included an assessment of the proposed future use of the property and equipment and their estimated useful lives. As a result of this assessment the Company recorded an impairment charge of $1.7 million for the three and nine months ended September 30, 2012, which is included in Restructuring Expense.

Intangible_Assets

Intangible Assets

9 Months Ended

Sep. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

NOTE 5. INTANGIBLE ASSETS

Intangible assets that have finite lives are amortized over their useful lives. The intangible assets, their original fair values and their net book values are detailed below as of September 30, 2013 and December 31, 2012:

Cost, Less

Accumulated

Net Book

Estimated

Impairment

Amortization

Value

Remaining

Charges

Useful Life

September 30, 2013:

Technology and intellectual property

1,757,651

(147,700

)

1,609,951

11.0 to 20.0 years

December 31, 2012:

Technology and intellectual property

988,629

(124,219

)

864,410

11.6 to 20.0 years

Total intangible amortization expense was $12,000 and $61,000 for the three months ended September 30, 2013 and 2012, respectively. Total intangible amortization expense was $27,000 and $198,000 for the nine months ended September 30, 2013 and 2012, respectively.

Impairment of Intangible Assets

Intangible assets with estimable useful lives are amortized over their respective useful lives to their estimated residual values, and reviewed to determine if their estimable lives have decreased. Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever, in management’s judgment, conditions indicate a possible impairment. Such impairment tests compare the estimated undiscounted cash flows attributable to such assets to the carrying value of the asset. If an impairment is indicated, the asset is written down to its fair value based on an estimate of its discounted cash flows.

The Company reviewed the amortizable intangible assets acquired in the acquisition of LSGBV for impairment as of September 30, 2012 primarily due to LSGBV’s ongoing negative cash flows from operations, among other factors. This review included an assessment of the current use of these intangible assets and their estimated useful lives. As a result of this review, the Company recorded an impairment charge of $380,000 as of September 30, 2012.

The following table summarizes the total impairment charges recorded by the Company in the third quarter of 2012:

Patents acquired on the acquisition of LSGBV

15,984

Trademarks acquired on the acquisition of LSGBV

19,541

License agreements acquired on the acquisition of LSGBV

44,923

Customer relationships acquired on the acquisition of LSGBV

299,089

Total impairment charge

379,537

Lines_of_Credit

Lines of Credit	9 Months Ended
Lines of Credit	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Lines of Credit	'
	NOTE 6. LINES OF CREDIT
	Wells Fargo
	The Wells Fargo ABL provides the Company with borrowing capacity of up to $50.0 million, which capacity is equal to the sum of (i) 85% of its eligible accounts receivable plus $7.5 million of eligible inventory less certain allowances established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) Qualified Cash, plus (iii) the amount of the Ares Letter of Credit Facility. As of September 30, 2013 and December 31, 2012, the Company had $30.5 million and $1.5 million, respectively, outstanding under the Wells Fargo ABL and additional borrowing capacity of $14.1 million and $48.5 million, respectively.
	As of September 30, 2013, eligible collateral included $8.2 million of accounts receivable, $25.7 million of inventory and $10.0 million of Qualified Cash. Borrowings under the Wells Fargo ABL bear interest at one of the following two rates (at the Company’s election): (a) the sum of (1) the greater of: (x) the federal funds rate plus 0.50%, (y) the daily three month LIBOR rate plus 1.0% and (z) Wells Fargo’s prime rate; and (2) 0.75%, 1.25% or 1.75%, as applicable, depending on the amount available for borrowing under the facility and subject to any reserves established by Wells Fargo in accordance with the terms of the Wells Fargo ABL; or (b) the sum of the daily three month LIBOR rate plus 3.0%, 3.5% or 4.0%, as applicable, depending on the amount available for borrowing under the facility and subject to any reserves established by Wells Fargo in accordance with the terms of the facility. The interest rate on the Wells Fargo ABL was 3.25% as of September 30, 2013.
	The Company is required to pay certain fees, including an unused line fee ranging from 0.375% to 1.0% of the unused portion of the Wells Fargo ABL. Outstanding loans may be prepaid without penalty or premium, except that the Company is required to pay a termination fee ranging from $250,000 to $500,000 (depending on the date of termination) if the facility is terminated by the Company prior to the scheduled maturity date of April 2, 2014 or by Wells Fargo during a default period.
	The Wells Fargo ABL contains financial covenants that limit the Company’s ability to incur additional indebtedness or guaranty indebtedness of others, create liens on the Company’s assets, enter into mergers or consolidations, dispose of assets, prepay indebtedness, make changes to the Company’s governing documents and certain agreements, pay dividends or make other distributions on the Company’s capital stock, redeem or repurchase capital stock, make investments, including acquisitions and enter into certain transactions with affiliates. The Company is at all times required to maintain (i) a Borrowing Base that exceeds the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million of Qualified Cash. The Company would be required to comply with certain specified EBITDA requirements in the event that it has less than $2.0 million available for borrowing on the Wells Fargo ABL. The Wells Fargo ABL also contains customary events of default and affirmative covenants, a subjective acceleration clause, a lockbox requirement and cross default provisions.
	On March 31, 2013, the Company entered into Amendment No. 6 to the Wells Fargo ABL, which among other things, (i) extended the maturity date of the Wells Fargo ABL to April 2, 2014, and (ii) reduced the maximum credit available under the Wells Fargo ABL by $2.5 million (from $50.0 million to $47.5 million) on November 22, 2013 if (x) the Company’s consolidated earnings (loss) before interest, tax, depreciation and amortization for the nine month period ending on September 30, 2013 is greater than $(20.2 million) and (y) excess availability under the Wells Fargo ABL on November 22, 2013 is less than $10.0 million.
	Pursuant to Amendment No. 6, Wells Fargo also waived certain events of default under the Wells Fargo ABL related to the Company’s creation of Lighting Science India Private Limited (“LSIPL”), its subsidiary in India. The Company also agreed to pledge 65% of the issued and outstanding capital stock of LSIPL as collateral supporting the Wells Fargo ABL. Further, Amendment No. 6 permits the Company to make additional advances to certain affiliates (including LSIPL) in an amount not to exceed $500,000 from the date of Amendment No. 6 through October 1, 2013, and in an amount not to exceed $250,000 thereafter.
	On June 4, 2013, the Company entered into Amendment No. 7 to the Wells Fargo ABL, which among other things, increased the limit on the aggregate amount of all letters of credit the Company may issue (the “Letter of Credit Limit”) to $7.0 million from $2.0 million.
	Ares Capital
	On September 21, 2011, the Company entered into the Ares Letter of Credit Facility, a $25.0 million standby letter of credit issued by Ares Capital in favor of Wells Fargo for the benefit of the Company. As a condition to Ares Capital’s agreement to provide the Ares Letter of Credit Facility for the benefit of the Company, the Company entered into the Second Lien Letter of Credit, Loan and Security Agreement (the “Ares Loan Agreement”) with Ares Capital. In accordance with the Ares Loan Agreement, the Company agreed to reimburse Ares Capital for any amounts drawn on the Ares Letter of Credit Facility and to permanently reduce the face amount of the Ares Letter of Credit Facility by such amount. Further, the Company agreed that any such reimbursement obligation would automatically convert into a term loan (an “Ares Term Loan”) by Ares Capital to the Company secured by substantially all of the assets of the Company. The Ares Letter of Credit Facility may only be used to collateralize borrowings pursuant to the Wells Fargo ABL.
	Interest on any Ares Term Loan accrues at either (at the Company’s election): (a) 9.0% per annum plus the greater of (i) The Wall Street Journal prime rate, (ii) the sum of 0.50% per annum and the federal funds rate and (iii) the sum of 1.0% per annum and the higher of the daily one month LIBOR rate and 1.5% per annum; or (b) 10.0% per annum plus the greater of (i) 1.5% per annum and (ii) the daily one-month LIBOR rate. The Company is required to pay certain fees to Ares Capital under the Ares Loan Agreement including: (a) an annual administrative fee of $50,000, payable quarterly in advance; (b) a quarterly fronting fee equal to the product of the average daily undrawn face amount of the Ares Letter of Credit Facility multiplied by 0.75% per annum; and (c) a quarterly letter of credit fee equal to the product of the average daily undrawn face amount of the Ares Letter of Credit Facility multiplied by 10.0% per annum.
	On April 1, 2013, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Ares Letter of Credit Facility (the “Ares Amendment”), which extends the maturity date of the Ares Letter of Credit Facility to April 2, 2014. Pursuant to the Ares Amendment, Ares Capital also waived certain events of defaults under the Ares Letter of Credit Facility related to our creation of LSIPL. The Company also agreed to pledge 65% of the issued and outstanding capital stock of LSIPL as collateral supporting the Ares Letter of Credit Facility.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	NOTE 7. FAIR VALUE MEASUREMENTS

	The Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) defines fair value as the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor.

	Assets and liabilities measured at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity associated with the inputs to a fair valuation of these assets and liabilities and are based on (i) unadjusted quoted prices that are available in active markets for the identical assets or liabilities at the measurement date (Level 1); (ii) quoted prices in non-active markets or inputs that are observable either directly or indirectly for substantially the full term of the asset or liability (Level 2); and (iii) prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (Level 3).

	The Company has recorded the Riverwood Warrants, the September 2012 Warrants and the Pegasus Commitment (each as defined in Note 9 below) and the Pegasus Warrant (defined in Note 8 below) at their fair values using the Monte Carlo valuation method and they are valued on a recurring basis at the end of each reporting period.



	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2013, according to the valuation techniques the Company used to determine their fair values:




		Fair Value Measurement as of September 30, 2013
		Quoted Price in			Significant Other		Significant
		Active Markets for			Observable Inputs		Unobservable Inputs
		Identical Assets
		Level 1			Level 2		Level 3
	Assets (Recurring):
	Pegasus Commitment	$	—		$	—	$	1,600,000


	Liabilities (Recurring):
	Riverwood Warrants	$	—		$	—	$	6,639,952
	September 2012 Warrants		—			—		1,600,000
	Pegasus Warrant		—			—		3,700,000

		$	—		$	—	$	11,939,952

	The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs as defined above for the nine months ended September 30, 2013:




		Total			Pegasus		Riverwood			September 2012			Pegasus
		Total			Commitment		Warrants			Warrant			Warrant
	Beginning balance, December 31, 2012	$	(7,960,705	)	$	1,360,000	$	(7,960,705	)	$	(1,360,000	)	$	—
	Realized and unrealized gains (losses) included in net loss		1,320,753			240,000		1,320,753			(240,000	)		—
	Purchases, sales, issuances and settlements		(3,700,000	)		—		—			—			(3,700,000	)
	Transfers in or out of Level 3		—			—		—			—			—

	Ending balance, September 30, 2013	$	(10,339,952	)	$	1,600,000	$	(6,639,952	)	$	(1,600,000	)	$	(3,700,000	)

	As of September 30, 2013, the Company had no financial assets or liabilities that were accounted for at fair value on a non-recurring basis.

Series_J_Redeemable_Convertibl

Series J Redeemable Convertible Preferred Stock	9 Months Ended
Series J Redeemable Convertible Preferred Stock	Sep. 30, 2013
Text Block [Abstract]	'
Series J Redeemable Convertible Preferred Stock	'
	NOTE 8. SERIES J REDEEMABLE CONVERTIBLE PREFERRED STOCK

	Series J Preferred Stock

	On September 11, 2013, the Company entered into the Series J Subscription Agreement with Riverwood Holdings, PCA Holdings and Holdings II, pursuant to which the Company issued an aggregate of 17,394 shares of Series J Preferred Stock, at a price of $1,000 per share, for gross proceeds of $17.4 million. The Company issued 12,500, 2,500 and 2,394 shares of Series J Preferred Stock to Holdings II, PCA Holdings and Riverwood Holdings, respectively. As compensation for advisory services provided by Pegasus, on September 11, 2013, the Company issued a warrant to Holdings II (the “Pegasus Warrant”) representing the right to purchase 10,000,000 shares of common stock at a variable exercise price that will be determined on the date of exercise.

	In connection with the Series J Preferred Offering, and pursuant to the certificates of designation governing the shares of the Company’s Series H Preferred Stock (the “Series H Certificate of Designation”) and Series I Preferred Stock (the “Series I Certificate of Designation”), the Company agreed to offer to all holders of shares of Series H Preferred Stock (defined in Note 9), and Series I Preferred Stock (defined in Note 9), the right to purchase shares of Series J Preferred Stock based upon such holder’s ownership of the Company’s outstanding shares of common stock on a fully diluted, as converted basis (the “Preemptive Rights Offering”). Pursuant to the Series J Subscription Agreement, Pegasus committed to purchase the number of shares of Series J Preferred Stock equal to 20,000 minus the aggregate number of shares of Series J Preferred Stock issued in the Series J Preferred Offering and the Preemptive Rights Offering at a price per share equal to the Stated Value (the “Pegasus Series J Commitment”). On October 16, 2013, the Company completed the Preemptive Rights Offering and issued an aggregate of 1,449 shares of Series J Preferred Stock at the Stated Value, for aggregate gross proceeds of $1.4 million. Pursuant to the Pegasus Series J Commitment, Pegasus is obligated to purchase 1,157 shares of Series J Preferred Stock on or before November 19, 2013 at the Stated Value, for aggregate gross proceeds of $1.2 million.

	The Series J Preferred Stock is senior to the Series H Preferred Stock, the Series I Preferred Stock and the common stock and is entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each share of Series J Preferred Stock is convertible at any time, at the election of the holder thereof, into the number of shares of common stock (the “Optional Conversion Shares”) equal to the quotient obtained by dividing (a) the Stated Value of such shares of Series J Preferred Stock by (b) the $0.95 conversion price, subject to certain adjustments.

	The Company will redeem all outstanding shares of Series J Preferred Stock for an amount in cash equal to the Liquidation Amount (as defined below) upon the Company’s receipt of a notice from the holders of Series H Preferred Stock that would require the Company to redeem the shares of Series H Preferred Stock pursuant to the Series H Certificate of Designation. The redemption of any shares of Series J Preferred Stock would be senior and prior to any redemption of Series H Preferred Stock or Series I Preferred Stock and any holder of shares of Series J Preferred Stock may elect to have less than all or none of such holder’s shares of Series J Preferred Stock redeemed. At any time after the Company has redeemed any shares of Series H Preferred Stock, at any time thereafter each holder of shares of Series J Preferred Stock may elect to have all or a portion of such holder’s shares of Series J Preferred Stock redeemed by the Company for an amount in cash equal to the Liquidation Amount of such shares of Series J Preferred Stock.

	The “Liquidation Amount” of each share of Series J Preferred Stock is equal to the greater of (a) the fair market value of the Optional Conversion Shares and (b) if the applicable reference date occurs (i) on or prior to May 26, 2014, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 1.75; and (ii) subsequent to May 26, 2014, an amount equal to the product obtained by multiplying (A) the Stated Value by (B) 2.0.

	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the shares of Series J Preferred Stock are recorded as mezzanine equity because such shares contain terms that allow the holder to redeem the shares for cash, and for which redemption is not solely within the control of the Company. In accordance with ASC 480-10-S99, the Company will recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the shares of Series J Preferred Stock to equal the redemption value at the end of each reporting period. The Series J Preferred Stock was recorded at redemption value as of September 11, 2013, which included a deemed dividend due to the redemption feature and resulted in the Company recording an increase of $21.6 million to the Series J Preferred Stock with an offset in additional paid-in capital. There was no change in the redemption value as of September 30, 2013.

	Pegasus Warrant

	The Pegasus Warrant was issued to Holdings II on September 11, 2013 in consideration for advisory services provided by Pegasus. The Pegasus Warrant represents the right to purchase 10,000,000 shares of common stock at a variable exercise price that will be determined on the date of exercise. The exercise price will be equal to the difference obtained by subtracting (a) the fair market value for each share of common stock on the day immediately preceding the date of exercise from (b) the quotient obtained by dividing (i) approximately 2.764% of the amount by which the total equity value of the Company exceeds $523.9 million (as may be adjusted for subsequent capital raises) by (ii) the number of shares of common stock underlying the Pegasus Warrant; provided that for so long as the total equity value of the Company is less than or equal to $523.9 million (as may be adjusted for subsequent capital raises) the Pegasus Warrant will not be exercisable. The Pegasus Warrant provides for certain anti-dilution adjustments and if unexercised, expires on May 25, 2022.

	The Pegasus Warrant is considered a derivative financial instrument in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the variable nature of the warrant exercise price. The Pegasus Warrant was recorded as a liability at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. There was no change in fair value of the Pegasus Warrant for the period from September 11, 2013 (date of issuance) through September 30, 2013.

Series_H_and_Series_I_Redeemab

Series H and Series I Redeemable Convertible Preferred Stock	9 Months Ended
	Sep. 30, 2013
Text Block [Abstract]	'
Series H and Series I Redeemable Convertible Preferred Stock	'
	NOTE 9. SERIES H AND SERIES I REDEEMABLE CONVERTIBLE PREFERRED STOCK

	Series H and I Preferred Stock

	On May 25, 2012, the Company entered into a preferred stock subscription agreement (the “Series H and I Subscription Agreement”) with Riverwood Holdings and certain other purchasers, pursuant to which the Company issued 60,705 shares of Series H Convertible Preferred Stock (the “Series H Preferred Stock”) and 6,364 shares of Series I Convertible Preferred Stock (the “Series I Preferred Stock” and together with the Series H Preferred Stock, the “Preferred Shares”) at a price of $1,000 per Preferred Share (the “Series H and I Preferred Offering”), for gross proceeds of $67.1 million. As compensation for Riverwood’s provision of certain financial and structural analysis, due diligence investigations, corporate strategy and other advice and negotiation assistance to the Company in connection with the Series H and I Preferred Offering, the Company issued a warrant to Riverwood Management (the “Riverwood Warrant”) representing the right to purchase 18,092,511 shares of common stock at a variable exercise price that will be determined on the date of exercise.



	On September 25, 2012, the Company also entered into a separate preferred stock subscription agreement (together, the “September 2012 Subscription Agreements”) with each of (i) Portman Limited (“Portman”) and (ii) Cleantech Europe II (A) LP (“Cleantech A”) and Cleantech Europe II (B) LP (“Cleantech B” and together with Cleantech A, “Zouk”), pursuant to which the Company issued 49,000 shares of Series H Preferred Stock at a price of $1,000 per shares of Series H Preferred Stock (the “September 2012 Preferred Offering”), for gross proceeds of $49.0 million. In conjunction with the September 2012 Preferred Offering, the Company also issued warrants to each of Portman, Cleantech A and Cleantech B to purchase 4,000,000, 3,406,041 and 593,959 shares of common stock, respectively (the “September 2012 Warrants”).

	On September 11, 2013, in connection with the Series J Preferred Offering, Riverwood and Pegasus, as the “Primary Investors” of the Series H Preferred Stock and Series I Preferred Stock, respectively, approved the Amended and Restated Series H Certificate of Designation and the Amended and Restated Series I Certificate of Designation (collectively, the “Amended Certificates of Designation”) and certain holders of shares of Series H Preferred Stock and Series I Preferred Stock agreed to make certain amendments to the agreements entered into in connection with the purchase of (i) the shares of Series H Preferred Stock and Series I Preferred Stock and (ii) the Company’s previously issued shares of Series F Preferred Stock and Series G Preferred Stock, which were subsequently converted into shares of Series H Preferred Stock and Series I Preferred Stock (collectively, the “Preferred Stock Subscription Agreements”).

	The Amended Certificates of Designation amend the terms of the Series H Certificate of Designation and Series I Certificate of Designation to, among other things, (i) reduce the price used to determine the number of shares of common stock each share of Series H Preferred Stock and Series I Preferred Stock can be converted into at the election of each holder from $1.18 to $0.95 (the “Conversion Price”); (ii) remove the covenant requiring the Company to comply with certain minimum thresholds related to the Company’s consolidated earnings before interest, taxes, depreciation and amortization for 2013 and 2014; (iii) increase, from $10 million to $50 million, the amount of indebtedness the Company can incur without the consent of Riverwood and Pegasus (in each case, in their capacity as “Primary Investor” of the Series H Preferred Stock and Series I Preferred Stock, respectively) and (iv) make certain other clarifying amendments to the Certificates of Designation. The reduction in the Conversion Price for the Series H Preferred Stock and the Series I Preferred Stock resulted in the Company recording a deemed dividend of $14.4 million, which is reflected in earnings per share allocated to controlling shareholders and noncontrolling shareholders.

	The Preferred Shares are entitled to dividends of the same type as any dividends or other distribution of any kind payable or to be made on outstanding shares of common stock, on an as converted basis. Each Preferred Share is convertible at any time, at the election of the holder thereof, into the Optional Conversion Shares equal to the quotient obtained by dividing (a) the $1,000 by (b) the $0.95 conversion price, subject to certain adjustments.

	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the Preferred Shares are recorded as mezzanine equity because the Preferred Shares contain terms that allow the holder to redeem the shares for cash, and for which redemption is not solely within the control of the Company. In accordance with ASC 480-10-S99, the Company will recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the Preferred Shares to equal the redemption value at the end of each reporting period. There was no change in the redemption value during the period ending September 30, 2013.

	Riverwood Warrants

	The Riverwood Warrant was issued to Riverwood Management on May 25, 2012 in consideration for services provided in connection with the Series H and I Preferred Offering. The Riverwood Warrant represents the right to purchase 18,092,511 shares of common stock at a variable exercise price that will be determined on the date of exercise. Subsequent to the issuance of the Riverwood Warrant, Riverwood assigned a portion of the Riverwood Warrant representing the right to purchase an aggregate of 5,427,751 shares of common stock to certain of the former members of Riverwood Management. The exercise price will be equal to the difference obtained by subtracting (a) the fair market value for each share of common stock on the day immediately preceding the date of exercise from (b) the quotient obtained by dividing (i) 5% of the amount by which the total equity value of the Company exceeds $523.9 million (as may be adjusted for subsequent capital raises) by (ii) the number of shares of common stock underlying the Riverwood Warrants; provided that for so long as the total equity value of the Company is less than or equal to $523.9 million (as may be adjusted for subsequent capital raises) the Riverwood Warrants will not be exercisable. The Riverwood Warrants provide for certain anti-dilution adjustments and if unexercised, expire on May 25, 2022.

	The Riverwood Warrants are considered a derivative financial instrument in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the variable nature of the warrant exercise price. The Riverwood Warrants were recorded as a liability at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The change in fair value of the Riverwood Warrants was $(2.1) million and $2.4 million for the three months ended September 30, 2013 and 2012, respectively, and was included in the (increase) decrease in fair value of liabilities under derivative contracts in the consolidated statement of operations and comprehensive loss. The change in fair value of the Riverwood Warrants was $1.3 million and $2.7 million for the nine months ended September 30, 2013 and 2012, respectively, and was included in the decrease in fair value of liabilities under derivative contracts in the consolidated statement of operations and comprehensive loss.

	September 2012 Warrants and September 2012 Commitment Agreement

	In connection with the issuance of the September 2012 Warrants, on September 25, 2012, the Company entered into a Commitment Agreement (the “September 2012 Commitment Agreement”) with Pegasus, pursuant to which the Company is obligated to buy from Pegasus IV or its affiliates shares of common stock equal to the number of shares, if any, for which the September 2012 Warrants are exercised, up to an aggregate number of shares of common stock equal to the aggregate number of shares of common stock underlying all of the September 2012 Warrants (the “Pegasus Commitment”). The purchase price for any shares of common stock purchased by the Company pursuant to the Pegasus Commitment will be equal to the consideration paid to the Company pursuant to the September 2012 Warrants. With respect to any September 2012 Warrants exercised on a cashless basis, the consideration to Pegasus IV in exchange for the number of shares of common stock issued to the exercising holder of September 2012 Warrants would be the reduction in the Pegasus Commitment equal to the reduction in the number of shares underlying the September 2012 Warrants.

	Subject to certain limitations, Pegasus IV has the right to cancel its obligations to the Company pursuant to the September 2012 Commitment Agreement with respect to all or a portion of the Pegasus Commitment then outstanding (a “Pegasus Call”). Upon the exercise of a Pegasus Call, the Company will have the obligation to purchase that number of September 2012 Warrants equal to the Pegasus Commitment subject to the Pegasus Call for an amount equal to the consideration paid by Pegasus IV pursuant to such Pegasus Call.

	The September 2012 Warrants are exercisable on or after the tenth business day following the third anniversary of the Issuance Date at an exercise price of $0.72 per share of common stock. If unexercised, the September 2012 Warrants expire upon the earlier of (i) a Change of Control of the Company (as defined in the Series H Certificate of Designation) prior to the three-year anniversary of the Issuance Date; (ii) the occurrence of any event that results in holders of shares of Series H Preferred Stock having a right to require the Company to redeem the shares of Series H Preferred Stock prior to the three-year anniversary of the Issuance Date; (iii) consummation of a qualified public offering (“QPO”) (as defined in the Series H Certificate of Designation) prior to the three-year anniversary of the Issuance Date or (iv) receipt by the Company of a Redemption Notice (as defined in the Subscription Agreements). The September 2012 Warrants also provide for certain anti-dilution adjustments.

	The September 2012 Warrants are considered derivative financial instruments in accordance with ASC 815-10-15, “Derivatives and Hedging” due to the cash settlement feature in the instrument. The September 2012 Warrants were recorded as liabilities at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The increase in fair value of the September 2012 Warrants was $320,000 and $240,000 for the three and nine months ended September 30, 2013, respectively, and was included in additional paid-in capital. There was no change in fair value of the September 2012 Warrants for the period from September 25, 2012 (date of issuance) through September 30, 2012.

	The Pegasus Commitment is classified as a financial instrument under ASC 480, “Distinguishing Liabilities from Equity” due to the Company’s obligation to purchase its own shares in the event the September 2012 Warrants are exercised by the holders. The Pegasus Commitment was recorded as an asset at fair value using the Monte Carlo valuation method at issuance with changes in fair value measured and recorded at the end of each quarter. The change in fair value of the Pegasus Commitment was $320,000 and $240,000 for the three and nine months ended September 30, 2013, respectively, and was included in additional paid-in capital. The change in fair value of the Pegasus Commitment generally offsets the change in fair value of the September 2012 Warrants for the same period.

Series_G_Preferred_Units

Series G Preferred Units	9 Months Ended
Series G Preferred Units	Sep. 30, 2013
Text Block [Abstract]	'
Series G Preferred Units	'
	NOTE 10. SERIES G PREFERRED UNITS
	Series G Preferred Units
	On December 1, 2011, the Company entered into a Series G Preferred Unit Subscription Agreement (the “Series G Subscription Agreement”) with PCA Holdings, Pegasus IV, Holdings II, Leon Wagner, a member of the Company’s board of directors and certain accredited investors (together with Pegasus IV, PCA Holdings, Holdings II and any additional investors that may become party to the Series G Subscription Agreement, the “Series G Purchasers”). Pursuant to the Series G Subscription Agreement and subsequent subscription agreements on terms substantially similar to the Series G Subscription Agreement entered into between December 2011 and May 2012, the Company issued an aggregate of 52,358 Series G Preferred Units at a price per Series G Preferred Unit of $1,000 for total consideration of $52.4 million. Holdings II purchased an aggregate of 14,958 Series G Preferred Units; PCA Holdings purchased an aggregate of 17,650 Series G Preferred Units; Leon Wagner purchased an aggregate of 6,500 Series G Preferred Units; and the additional accredited investors purchased an aggregate of 13,250 Series G Preferred Units.
	In accordance with ASC 480, “Distinguishing Liabilities from Equity,” the shares of Series G Preferred Stock were recorded initially at fair value as a liability as the Series G Preferred Stock may have required settlement in a variable number of shares of common stock. Subsequent to initial recognition, the shares of Series G Preferred Stock were recorded at the present value of the amount to be paid at settlement, accruing interest cost using the rate implicit at inception. The common stock was recorded to equity at fair value and was not subsequently revalued. The difference between the amount recorded at issuance and the original issuance price was being accreted using the effective interest method over the term of the Series G Preferred Stock. Accretion of Series G Preferred Stock was $0 and $7.5 million for the three and nine months ended September 30, 2012, respectively.
	Pursuant to the Series G Subscription Agreement, if, at any time while shares of Series G Preferred Stock remained outstanding, the Company issued securities (other than pursuant to the Company’s equity-based compensation plans) that resulted in gross proceeds to the Company of at least $50.0 million (a “Series G Subsequent Transaction”), the Company was required to notify all holders of Series G Preferred Stock of the terms and conditions of such Series G Subsequent Transaction. Upon the consummation of the Series H and I Preferred Offering, the Company completed the required notification and, as described above, and pursuant to the Rollover Offering, all holders of Series G Preferred Stock converted their shares of Series G Preferred Stock into a number of shares of Series H Preferred Stock or Series I Preferred Stock (at the holder’s election) equal to the quotient obtained by dividing the aggregate liquidation value of the outstanding shares of Series G Preferred Stock held by each holder by the stated value of $1,000 per share. Each holder retained all of the shares of common stock issued as part of the Series G Preferred Units. Upon this conversion of the Series G Preferred Stock, each share of Series G Preferred Stock was valued at its accrued value, which included the initial fair value plus any dividends accrued through the date of conversion.
	Series G Preferred Stock Annual Cumulative Dividend
	Each share of Series G Preferred Stock was entitled to an annual cumulative dividend of, (i) initially, 10.0%, (ii) commencing on November 17, 2012, 15.0%, and (iii) commencing on February 21, 2014, 18.0%, on the accrued value of such share. The dividend accrued daily and was scheduled to compound on (i) November 17, 2012 and, (ii) from and after November 17, 2012, December 31 and June 30 of each year.

	The dividend was scheduled to accrue over the term of the Series G Preferred Stock on a weighted average rate based upon the applicable dividend rate over the term. On each dividend payment date subsequent to November 17, 2012, such dividend was required to be paid to each holder in cash semi-annually in arrears. The Company was only required to pay such dividend in cash to the extent that such payment would not result in an event of default under the Company’s (i) Wells Fargo ABL or (ii) Ares Loan Agreement. Any dividend that was scheduled to accrue on or after November 17, 2012, and was required to be paid in cash but was not actually paid in cash, was to continue to accrue and compound and be added to the accrued value of the Series G Preferred Stock.
	During the three and nine months ended September 30, 2012, the Company recorded $0 and $1.8 million of dividends expense on the Series G Preferred Stock, respectively.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]	'
Stockholders' Equity	'
	NOTE 11. STOCKHOLDERS’ EQUITY
	For the three and nine months ended September 30, 2013, the Company recorded expense of $238,000 related to restricted stock awards and $0 and $20,000, respectively, related to stock options issued to the Company’s directors. For the three and nine months ended September 30, 2012, the Company recorded expense of $302,000 and $966,000, respectively, related to restricted stock awards and $11,000 and $129,000, respectively, related to stock options issued to the Company’s directors.
	On January 2, 2013, Jeremy S. M. Cage was appointed Chief Executive Officer and the Company issued 500,000 shares of restricted stock to Mr. Cage as part of his compensation package. On March 22, 2013, the Company issued 192,308 shares of restricted stock to Brad Knight as part of his compensation package. For the three and nine months ended September 30, 2013, the Company recorded expense of $49,000 and $119,000, respectively, related to the restricted stock awards issued to Messrs. Cage and Knight.

	Warrants for the Purchase of Common Stock
	On January 13, 2011, the Company issued a warrant (the “THD Warrant”) to The Home Depot, Inc. (“The Home Depot”) pursuant to which The Home Depot may purchase up to 5.0 million shares of the Company’s common stock at an exercise price of $2.00 per share, subject to certain vesting conditions. The THD Warrant was issued in connection with the Company’s Strategic Purchasing Agreement with The Home Depot, which it entered into on July 23, 2010 and pursuant to which it supplies The Home Depot with LED retrofit lamps and fixtures. The THD Warrant provided that 1.0 million shares of common stock would be eligible for vesting following each year ending December 31, 2011 through December 31, 2015, subject to The Home Depot having gross product orders from the Company, in dollar terms, that are at least 20% more than the gross product orders in the immediately preceding year. For the shares underlying the THD Warrant to be eligible for vesting following the years ending December 31, 2014 and 2015, The Home Depot would be required to extend the Strategic Purchasing Agreement for additional one-year periods beyond its initial term of three years. On August 12, 2013, the Company and The Home Depot entered into Amendment No. 1 to the Strategic Purchasing Agreement which, among other things, extended the term of the Agreement for an additional three years. As of May 25, 2012, as a result of the Series H and I Preferred Offering, the exercise price of the THD Warrants adjusted, pursuant to the terms of such warrants, from $2.00 to $1.95 per share of common stock. The number of shares of common stock into which the THD Warrants were exercisable also adjusted, pursuant to the terms of the warrant, from 5,000,000 to 5,123,715 shares. Each vested portion of the THD Warrant will expire on the third anniversary following the vesting of such portion.
	As of September 30, 2013, the following warrants for the purchase of common stock were outstanding:


	Warrant Holder	Reason for Issuance	Number of		Exercise Price	Expiration Date
			Common
			Shares

	Investors in rights offering	Series D Warrants		567,912	$5.57 to $5.59	March 3, 2022 through
						April 19, 2022

	The Home Depot	Purchasing agreement		5,123,715	$1.95	2014 through 2018

	RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760	Variable	25-May-22

	Certain other investors	Riverwood Warrants		5,427,751	Variable	25-May-22

	Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$0.72	September 25, 2022

	Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$0.72	September 25, 2022

	Portman Limited	September 2012 Warrants		4,000,000	$0.72	September 25, 2022

	Aquillian Investments LLC	Private Placement Series H		830,508	$1.18	September 25, 2017

	Pegasus	Pegasus Warrant		10,000,000	Variable	25-May-22


				42,614,646

	As of September 30, 2013, all warrants shown in the table above were fully vested and exercisable, except a portion of the THD Warrant, the Riverwood Warrants, the September 2012 Warrants and the Pegasus Warrant. As discussed above, 2,049,486 shares issuable pursuant to the THD Warrant vested during 2012 and 2011, when the product purchases for these periods satisfied the prescribed vesting conditions, and 3,074,229 shares remain subject to vesting in accordance with similar product purchasing terms. Pursuant to the terms of the Riverwood Warrants and the Pegasus Warrant, these were not exercisable as of September 30, 2013 because the aggregate fair market value of the Company’s outstanding shares of common stock (as determined in accordance with the terms of the Riverwood Warrants and the Pegasus Warrant) was less than $523.9 million (subject to adjustment in accordance with the terms of the Riverwood Warrants and the Pegasus Warrant). The September 2012 Warrants will become exercisable on October 9, 2015.
	The fair value of the THD Warrant is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until they have been earned for each year and these adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot. As of September 30, 2013 and 2012, the Company determined that a portion of the THD Warrant was expected to vest during the period based on purchases made by The Home Depot during the nine months ended September 30, 2013 and 2012 and, accordingly, recorded (increase)/reductions in revenue of $9,000 and $23,000 for the three and nine months ended September 30, 2013, respectively, and $(257,000) and $458,000 for the three and nine months ended September 30, 2012, respectively.

Earnings_Loss_Per_Share

Earnings (Loss) Per Share	9 Months Ended
Earnings (Loss) Per Share	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Earnings (Loss) Per Share	'
	NOTE 12: EARNINGS (LOSS) PER SHARE

	Upon issuance of the LSGC Letter Agreement on January 17, 2012, the Company determined that two classes of common stock had been established for financial reporting purposes only, with common stock attributable to controlling stockholders representing shares beneficially owned and controlled by Pegasus Capital and its affiliates and the common stock attributable to noncontrolling stockholders representing the minority interest stockholders. For the three and nine months ended September 30, 2013 and 2012, the Company computed net loss per share of noncontrolling stockholders and controlling stockholders common stock using the two-class method. Net loss from operations is initially allocated based on the underlying common shares held by controlling and noncontrolling stockholders. The allocation of the net losses attributable to the common stock attributable to controlling stockholders is then reduced by the amount of the deemed dividend related to the Repurchase Obligation, while the allocation of net losses attributable to the common stock attributable to noncontrolling stockholders is increased by the amount of the deemed dividend related to the Repurchase Obligation (See Note 13 for further discussion).

	The following table sets forth the computation of basic and diluted net loss per share of common stock:




		For the Three Months Ended September 30
		2013						2012
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss attributable to common stock	$	(21,156,773	)	$	(4,346,354	)	$	(19,990,435	)	$	(4,005,071	)
	Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(17,910,579	)		(3,679,470	)		—			—
	Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders		(11,982,712	)		(2,461,676	)		—			—
	Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders		—			—			(43,320,722	)		(8,679,278	)

	Undistributed net loss	$	(51,050,064	)	$	(10,487,500	)	$	(63,311,157	)	$	(12,684,349	)


	Basic and diluted weighted average number of common shares outstanding		170,672,339			35,062,174			170,560,715			34,171,729


	Basic and diluted net loss per common share	$	(0.30	)	$	(0.30	)	$	(0.37	)	$	(0.37	)




		For the Nine Months Ended September 30
		2013						2012
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss attributable to common stock	$	(47,896,411	)	$	(9,822,624	)	$	(77,840,649	)	$	(15,108,629	)
	Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(17,915,855	)		(3,674,194	)		—			—
	Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders		(11,986,242	)		(2,458,146	)		—			—
	Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders		—			—			12,488,175			(12,488,175	)
	Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders		—			—			(167,913,898	)		(32,591,568	)

	Undistributed net loss	$	(77,798,508	)	$	(15,954,964	)	$	(233,266,372	)	$	(60,188,372	)


	Basic and diluted weighted average number of common shares outstanding		170,645,985			34,996,177			171,573,632			33,301,911


	Basic and diluted net loss per common share	$	(0.46	)	$	(0.46	)	$	(1.36	)	$	(1.81	)

	Basic earnings per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share is computed in the same manner as basic earnings per share except the number of shares is increased to assume exercise of potentially dilutive stock options, unvested restricted stock and contingently issuable shares using the treasury stock method and convertible preferred shares using the if-converted method, unless the effect of such increases would be anti-dilutive. The Company had 190.4 million and 111.1 million common stock equivalents for the three months ended September 30, 2013 and 2012, respectively, and 186.8 million and 53.0 million common stock equivalents for the nine months ended September 30, 2013 and 2012, respectively, which were not included in the diluted net loss per common share as the common stock equivalents were anti-dilutive, as a result of being in a net loss position.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 13: RELATED PARTY TRANSACTIONS

	Effective June 23, 2010, the Company entered into a support services agreement with Pegasus Capital (the “Original Support Services Agreement”), pursuant to which the Company agreed to pay Pegasus Capital $187,500 for each of the four calendar quarters following the effective date of the Original Support Services Agreement and $125,000 for each of the four calendar quarters thereafter in exchange for certain support services during such periods. The Original Support Services Agreement expired on June 30, 2012. On May 25, 2012, the Company entered into a new Support Services Agreement (“2012 Support Services Agreement”) with Pegasus Capital, pursuant to which the Company agreed to pay Pegasus Capital $125,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The 2012 Support Services Agreement expires upon the earlier of: (i) June 30, 2017; (ii) a Change of Control or (iii) a QPO. During the first 30 days of any calendar quarter, the Company has the right to terminate the 2012 Support Services Agreement, effective immediately upon written notice to Pegasus Capital. Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Company’s largest stockholders and beneficially owned approximately 82.2% of the Company’s common stock as of September 30, 2013.



	On January 17, 2012, the Company entered into the LSGC Letter Agreement with LSGC Holdings pursuant to which it agreed to the Repurchase Obligation. In accordance with the LSGC Letter Agreement, the Company agreed to pay Pegasus IV a fee of $250,000 for expenses incurred by Pegasus IV and its affiliates related to the these transactions. This fee was recognized as interest expense over the life of the Series G Preferred Units. For the three and nine months ended September 30, 2012, the Company recognized related party interest expense of $0 and $250,000, respectively. In addition, during the three and nine months ended September 30, 2012, the Company recorded $0 and $250,000, respectively, of management fees pursuant to the Original Support Services Agreement and the 2012 Support Services Agreement, included in selling, distribution and administrative expense. For the three and nine months ended September 30, 2013 there was no related party interest expense or management fees incurred.

	On May 25, 2012, the Company entered into a Support Services Agreement (the “Riverwood Support Services Agreement”) with Riverwood Holdings and Riverwood Management, pursuant to which the Company agreed to pay Riverwood Holdings $20,000 for the period from May 25, 2012 through June 30, 2012 and thereafter $50,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The Riverwood Support Services Agreement expires upon the earlier of: (i) May 25, 2022, (ii) such date that Riverwood Management and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the Preferred Offering, on an as-converted basis (together with any shares of common stock issued upon conversion thereof); (iii) such date that the Company and Riverwood may mutually agree in writing (iv) a Change of Control or (v) a QPO. In addition, the Company has brought in several employees of Riverwood to provide consulting services, including Brad Knight, who served as the Company’s Chief Operations Officer until July 8, 2013 and now leads the transition of our manufacturing operations to our contract manufacturer in Asia. During the three and nine months ended September 30, 2013, the Company incurred $656,000 and $1.7 million, respectively, of consulting fees for services provided by Riverwood, included in selling, distribution and administrative expense. During the three and nine months ended September 30, 2012, the Company incurred $387,000 and $648,000, respectively, of consulting fees for services provided by Riverwood, included in selling, distribution and administrative expense.

	In connection with the September 2012 Preferred Offering, the Company entered into a Support Services Agreement (the “Zouk Support Services Agreement”) with Zouk, pursuant to which the Company agreed to pay Zouk $100,000 each calendar quarter beginning with the quarter ended September 30, 2012, in exchange for certain support services during such periods. The Zouk Support Services Agreement expires upon the earlier of: (i) September 25, 2022; (ii) such date that Zouk and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the September 2012 Preferred Offering, on an as-converted basis; (iii) such date that the Company and Zouk may mutually agree in writing; (iv) a Change of Control and (v) a QPO.

	On September 25, 2012 and in connection with the September 2012 Preferred Offering each of Pegasus Capital, Riverwood Holdings, Portman and Zouk entered into a Fee Waiver Letter Agreement, pursuant to which the parties agreed to suspend payment of the fees payable in connection with their respective support services or other agreements between the Company and such parties until revoked by their unanimous written consent.

	On September 11, 2013, the Company entered into the Series J Subscription Agreement with Riverwood Holdings, PCA Holdings and Holdings II, pursuant to which the Company issued an aggregate of 17,394 shares of Series J Preferred Stock at the Stated Value for gross proceeds of $17.4 million. The Company issued 12,500, 2,500 and 2,394 shares of Series J Preferred Stock to Holdings II, PCA Holdings and Riverwood Holdings, respectively. As compensation for advisory services provided by Pegasus, the Company issued the Pegasus Warrant to Holdings II on September 11, 2013, which represents the right to purchase 10,000,000 shares of common stock at a variable exercise price that will be determined on the date of exercise. Pursuant to the Series J Subscription Agreement and the Pegasus Series J Commitment, Pegasus is obligated to purchase 1,157 shares of Series J Preferred Stock on or before November 19, 2013 at the Stated Value, for aggregate gross proceeds of $1.2 million.

	During the three and nine months ended September 30, 2013, the Company incurred no consulting fees for services provided by GYRO LLC, a marketing company affiliated with Pegasus Capital. During the three and nine months ended September 30, 2012, the Company incurred consulting fees of $16,000 and $118,000, respectively, for services provided by GYRO LLC, which were included in selling, distribution and administrative expense.

	During the three and nine months ended September 30, 2013, the Company incurred consulting fees of $0 and $15,000, respectively, for services provided by T&M Protection Resources, primarily for the facility in Monterrey, Mexico, which were included in selling, distribution and administrative expense. T&M Protection Resources is a security company affiliated with Pegasus Capital. During the three and nine months ended September 30, 2012, the Company incurred consulting fees of $17,000 and $40,000, respectively, for services provided by T&M Protection Resources



	During the three and nine months ended September 30, 2013, the Company incurred no consulting fees for services provided by MWW Group, a marketing company owned by Michael Kempner, a former director of the Company. During the three and nine months ended September 30, 2012, the Company incurred consulting fees of $40,000 and $148,000, respectively, for public relations and corporate communications services provided by MWW Group, which were included in selling, distribution and administrative expense.

	On February 24, 2012, April 2, 2012 and May 2, 2012, the Company sold 2,000, 1,000 and 2,000 Series G Preferred Units to Leon Wagner, a member of the board of directors, for total proceeds of $5.0 million.

	On each of March 20, March 28, 2012 and May 18, 2012, the Company sold 2,000 Series G Preferred Units, respectively, to PCA Holdings for total proceeds of $6.0 million. On April 13, 2012, the Company sold 2,000 Series G Preferred Units to Holdings II for total proceeds of $2.0 million.

Concentrations_of_Credit_Risk

Concentrations of Credit Risk	9 Months Ended
Concentrations of Credit Risk	Sep. 30, 2013
Risks And Uncertainties [Abstract]	'
Concentrations of Credit Risk	'
	NOTE 14. CONCENTRATIONS OF CREDIT RISK
	For the three and nine months ended September 30, 2013, the Company had one customer whose revenue represented 56% and 52% of total revenue, respectively. For the three and nine months ended September 30, 2012, the Company had two customers whose revenue collectively represented 67% and 72% of total revenue, respectively.
	As of September 30, 2013, the Company had one customer whose accounts receivable balance represented 60% of accounts receivables, net of allowances. As of December 31, 2012, the Company had two customers whose accounts receivable balances collectively represented 77% of accounts receivables, net of allowances.

Restructuring_Expense

Restructuring Expense	9 Months Ended
Restructuring Expense	Sep. 30, 2013
Restructuring And Related Activities [Abstract]	'
Restructuring Expense	'
	NOTE 15. RESTRUCTURING EXPENSE

	In May 2012, the Company began implementing a new restructuring plan designed to build upon the restructuring plan initiated in the third quarter of 2011, to further increase efficiencies across the organization and lower its overall cost structure. This restructuring plan included a significant reduction in full time headcount in Mexico resulting from the Company’s continued shift of its manufacturing and production processes to the Company’s contract manufacturer in Mexico. The Company also replaced ten members of management in the United States, following the completion of the Series H and I Preferred Offering in May 2012.

	On September 24, 2012, the Company’s board of directors committed to the Mexico Closing. As of September 30, 2013, the Mexico Closing is substantially complete. The Mexico Closing was expected to result in the termination of approximately 520 employees, of which all but 1 were terminated by September 30, 2013. As of September 30, 2012, the Company had accrued expenses and charges related to the Mexico Closing of $1.7 million in severance and $1.7 million in non-cash asset impairment. The restructuring charges are included in the line item restructuring expenses in the consolidated statements of operations and comprehensive loss. For the three and nine months ended September 30, 2013, the Company recorded $55,000 and $184,000, respectively, in restructuring expense in the condensed consolidated statements of operations and comprehensive loss for each period, of which $99,000 was related to termination of the lease on the Mexico manufacturing facility. For the three and nine months ended September 30, 2012, the Company incurred $2.2 million and $4.1 million, respectively, of costs as a result of severance and termination benefits.

	In addition to the charges noted above, the Company expects to incur certain other charges in connection with the Mexico Closing. While the total estimate of these costs is not yet final, the Company currently expects to incur approximately $400,000 in expense with most of these remaining costs being incurred or accrued during the year ending December 31, 2013.

	As of September 30, 2013, the accrued liability associated with the restructuring charges consisted of the following:




		Workforce			Excess			Total
		Reduction			Facilities			Total
	Accrued liability as of December 31, 2012	$	1,620,956		$	—		$	1,620,956
	Charges		—			99,004			99,004
	Payments		(1,451,450	)		(99,004	)		(1,550,454	)

	Accrued liability as of September 30, 2013	$	169,506		$	—		$	169,506



	The remaining restructuring expense accrual that had not been paid as of September 30, 2013 of $170,000 is expected to be paid by December 31, 2013.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	NOTE 16. COMMITMENTS AND CONTINGENCIES
	Legal Proceedings
	The Company is subject to the possibility of loss contingencies arising in its business and such contingencies are accounted for in accordance with ASC Topic 450, “Contingencies.” In determining loss contingencies, the Company considers the possibility of a loss as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recorded when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. In the ordinary course of business, the Company is routinely a defendant in or party to various pending and threatened legal claims and proceedings. The Company believes that any liability resulting from these various claims will not have a material adverse effect on its results of operations or financial condition; however, it is possible that extraordinary or unexpected legal fees could adversely impact our financial results during a particular period. During its ordinary course of business, the Company enters into obligations to defend, indemnify and/or hold harmless various customers, officers, directors, employees, and other third parties. These contractual obligations could give rise to additional litigation costs and involvement in court proceedings.
	On June 22, 2012, Geveran Investments Limited (“Geveran”), a stockholder of the Company, filed a lawsuit against the Company and several others in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida. The action, styled Geveran Investments Limited v. Lighting Science Group Corp., et al., Case No. 12-17738 (07), names as defendants the Company; Pegasus Capital Advisors, L.P. (“Pegasus”) and nine other entities affiliated with Pegasus; Richard Weinberg, a former director and former interim CEO of the Company and a former partner at Pegasus; Gregory Kaiser, a former CFO of the Company; J.P. Morgan Securities, LLC (“J.P. Morgan”); and two employees of J.P. Morgan. Geveran seeks rescission of its $25.0 million investment in the Company, as well as recovery of attorneys’ fees and court costs, jointly and severally against the Company, Pegasus, Mr. Weinberg, Mr. Kaiser, J.P. Morgan and the two J.P. Morgan employees, for alleged violation of Florida securities laws. Geveran alternatively seeks unspecified money damages, as well as recovery of court costs, for alleged common law negligent misrepresentation against these same defendants. In July 2013, following the court’s partial grant of Defendants’ Motion to Dismiss the Complaint for More Definite Statement, Geveran served its First Amended Complaint, which adds three new claims for intentional torts.
	The Company has retained counsel, denies liability in connection with this matter, and intends to continue to vigorously defend against the claims asserted by Geveran. While the case is in its early stages and the outcome of any litigation is inherently difficult to predict, the Company currently believes that it has strong defenses against Geveran’s claims of rescission, that a grant of the remedy of rescission is unlikely and the amount of possible loss, if any, cannot be reasonably estimated at this time. The outcome, if unfavorable, could have a material adverse effect on the Company.
	On August 3, 2012, the Company and its co-defendants filed a motion to transfer this lawsuit from Broward County to the Circuit Court of the Eighteenth Judicial Circuit in and for Brevard County, Florida. On October 30, 2012, the court entered an order transferring the lawsuit to the Ninth Judicial Circuit in and for Orange County, Florida. In September 2013, that order was affirmed by the Fourth District Court of Appeals. The litigation is now proceeding in Orange County (Case No. 2012-CA-020121-O).
	The Company believes that, subject to the terms and conditions of the relevant policies (including retention and policy limits), directors and officers insurance coverage will be available to cover nearly all of the Company’s legal fees and costs in this matter. However, given the unspecified nature of Geveran’s maximum damage claims, insurance coverage may not be available for, or such coverage may not be sufficient to fully pay, a judgment or settlement in favor of Geveran. The Company has also paid a portion of the legal fees incurred by J.P. Morgan and its affiliates in this lawsuit in connection with the engagement of J.P. Morgan as placement agent for the Company’s private placement with Geveran, and expects to pay, in the future, the reasonable legal fees incurred by J.P. Morgan in this case. Such payments are not covered by the Company’s insurance coverage and have been substantial. The engagement letter executed with J.P. Morgan provides that the Company will indemnify J.P. Morgan and its affiliates from liabilities relating to J.P. Morgan’s activities as placement agent, unless such activities are finally judicially determined to have resulted from J.P. Morgan’s bad faith, gross negligence or willful misconduct.
	During October 2011, the Company was notified of a contract dispute between LSGBV, the Company’s subsidiary in the Netherlands, and one of its distributors in which the distributor is seeking monetary damages of approximately $1.2 million. Arbitration was held before the International Chamber of Commerce (“ICC”), in The Hague, in January 2013, and a decision is expected to be rendered in the near future, following the completion of a report by an ICC appointed economics expert. The Company estimates a loss of up to $300,000 in connection with this matter, and has provided a reserve for this amount in its financial statements.

Subsequent_Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 17. SUBSEQUENT EVENTS
	On October 15, 2013, the board of directors approved the dissolution of LSGBV and LSIPL as part of the Company’s efforts to reduce its cost structure and preserve cash flow.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.
Accounts Receivable	'
	Accounts Receivable
	The Company records accounts receivable at the invoiced amount when its products are shipped to customers or upon the completion of specific milestone billing requirements. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based upon age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of September 30, 2013 and December 31, 2012, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $396,000 and $1.2 million, respectively.
	As of September 30, 2013 and December 31, 2012, there were $8.2 million and $11.4 million, respectively, of eligible accounts receivable pledged as collateral for the Company’s line of credit with Wells Fargo Bank, N.A. (“Wells Fargo”).
Revenue Recognition	'
	Revenue Recognition
	The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once such terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.
	The Company recognizes revenue on certain long-term, fixed price, custom lighting design projects using the percentage of completion method based on the ratio of costs incurred for each contract in a period to the estimated total costs to be incurred for each contract. Contract costs include all direct material, direct labor and other indirect costs related to contract performance. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, estimated profitability and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.
	For smaller or shorter term custom lighting design projects or projects where estimated total costs cannot be determined, revenue is recognized using the completed contract method where recognition occurs upon substantial completion and acceptance by the customer of the project. Amounts received as deposits against future completion of completed contract method projects are recorded as unearned revenue until such projects are completed and title passes to the customer.
Product Warranties	'
	Product Warranties
	The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products and such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. Changes in the warranty liability for the nine months ended September 30, 2013 are as follows:


	Warranty provision as of December 31, 2012	$	2,108,012
	Additions to provision		1,977,142
	Less warranty costs		(2,653,091	)


	Warranty provision as of September 30, 2013	$	1,432,063
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments

	Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expense and other current liabilities are carried at amounts that approximate their fair value due to the short-term maturity of these instruments.

	The Riverwood Warrants, September 2012 Warrants and the Pegasus Commitment (each as defined in Note 9 below) and the Pegasus Warrant (defined in Note 8 below) were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2013
Accounting Policies [Abstract]	'
Summary of Warranty Provision	'
	Changes in the warranty liability for the nine months ended September 30, 2013 are as follows:




	Warranty provision as of December 31, 2012	$	2,108,012
	Additions to provision		1,977,142
	Less warranty costs		(2,653,091	)


	Warranty provision as of September 30, 2013	$	1,432,063

Detail_of_Certain_Balance_Shee1

Detail of Certain Balance Sheet Accounts (Tables)	9 Months Ended
Detail of Certain Balance Sheet Accounts (Tables)	Sep. 30, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Schedule of Inventory	'
	Inventories consisted of the following as of the dates indicated:


		September 30,			December 31,
		2013			2012

	Raw materials and components	$	14,135,586		$	15,150,768
	Work-in-process		1,856,235			1,309,447
	Finished goods		10,771,072			12,521,229


	Total inventory, net	$	26,762,893		$	28,981,444
Schedule of Property and Equipment, Net	'
	Property and equipment, net consisted of the following as of the dates indicated:


		September 30,			December 31,
		2013			2012

	Leasehold improvements	$	1,541,850		$	1,627,933
	Office furniture and equipment		1,180,563			1,255,244
	Computer hardware and software		9,369,127			8,924,424
	Tooling, production and test equipment		18,225,025			19,194,959
	Construction-in-process		126,692			134,240

	Total property and equipment		30,443,257			31,136,800
	Accumulated depreciation		(20,335,836	)		(14,593,687	)


	Total property and equipment, net	$	10,107,421		$	16,543,113

Intangible_Assets_Tables

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The intangible assets, their original fair values and their net book values are detailed below as of September 30, 2013 and December 31, 2012:

Cost, Less

Accumulated

Net Book

Estimated

Impairment

Amortization

Value

Remaining

Charges

Useful Life

September 30, 2013:

Technology and intellectual property

1,757,651

(147,700

)

1,609,951

11.0 to 20.0 years

December 31, 2012:

Technology and intellectual property

988,629

(124,219

)

864,410

11.6 to 20.0 years

Summary of impairment charges

The following table summarizes the total impairment charges recorded by the Company in the third quarter of 2012:

Patents acquired on the acquisition of LSGBV

15,984

Trademarks acquired on the acquisition of LSGBV

19,541

License agreements acquired on the acquisition of LSGBV

44,923

Customer relationships acquired on the acquisition of LSGBV

299,089

Total impairment charge

379,537

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Company's Financial Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis	'
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2013, according to the valuation techniques the Company used to determine their fair values:


		Fair Value Measurement as of September 30, 2013
		Quoted Price in			Significant Other		Significant
		Active Markets for			Observable Inputs		Unobservable Inputs
		Identical Assets
		Level 1			Level 2		Level 3
	Assets (Recurring):
	Pegasus Commitment	$	—		$	—	$	1,600,000


	Liabilities (Recurring):
	Riverwood Warrants	$	—		$	—	$	6,639,952
	September 2012 Warrants		—			—		1,600,000
	Pegasus Warrant		—			—		3,700,000

		$	—		$	—	$	11,939,952

Reconciliation of the Beginning and Ending Balances for Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis	'
	The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs as defined above for the nine months ended September 30, 2013:


		Total			Pegasus		Riverwood			September 2012			Pegasus
		Total			Commitment		Warrants			Warrant			Warrant
	Beginning balance, December 31, 2012	$	(7,960,705	)	$	1,360,000	$	(7,960,705	)	$	(1,360,000	)	$	—
	Realized and unrealized gains (losses) included in net loss		1,320,753			240,000		1,320,753			(240,000	)		—
	Purchases, sales, issuances and settlements		(3,700,000	)		—		—			—			(3,700,000	)
	Transfers in or out of Level 3		—			—		—			—			—

	Ending balance, September 30, 2013	$	(10,339,952	)	$	1,600,000	$	(6,639,952	)	$	(1,600,000	)	$	(3,700,000	)

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]	'
Schedule of Warrants for Purchase of Common Stock	'
	As of September 30, 2013, the following warrants for the purchase of common stock were outstanding:


	Warrant Holder	Reason for Issuance	Number of		Exercise Price	Expiration Date
			Common
			Shares

	Investors in rights offering	Series D Warrants		567,912	$5.57 to $5.59	March 3, 2022 through
						April 19, 2022

	The Home Depot	Purchasing agreement		5,123,715	$1.95	2014 through 2018

	RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760	Variable	25-May-22

	Certain other investors	Riverwood Warrants		5,427,751	Variable	25-May-22

	Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$0.72	September 25, 2022

	Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$0.72	September 25, 2022

	Portman Limited	September 2012 Warrants		4,000,000	$0.72	September 25, 2022

	Aquillian Investments LLC	Private Placement Series H		830,508	$1.18	September 25, 2017

	Pegasus	Pegasus Warrant		10,000,000	Variable	25-May-22


				42,614,646

Earnings_Loss_Per_Share_Tables

Earnings (Loss) Per Share (Tables)	9 Months Ended
Earnings (Loss) Per Share (Tables)	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Computation of Basic and Diluted Net Loss Per Share of Common Stock	'
	The following table sets forth the computation of basic and diluted net loss per share of common stock:


		For the Three Months Ended September 30
		2013						2012
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss attributable to common stock	$	(21,156,773	)	$	(4,346,354	)	$	(19,990,435	)	$	(4,005,071	)
	Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(17,910,579	)		(3,679,470	)		—			—
	Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders		(11,982,712	)		(2,461,676	)		—			—
	Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders		—			—			(43,320,722	)		(8,679,278	)

	Undistributed net loss	$	(51,050,064	)	$	(10,487,500	)	$	(63,311,157	)	$	(12,684,349	)


	Basic and diluted weighted average number of common shares outstanding		170,672,339			35,062,174			170,560,715			34,171,729


	Basic and diluted net loss per common share	$	(0.30	)	$	(0.30	)	$	(0.37	)	$	(0.37	)



		For the Nine Months Ended September 30
		2013						2012
		Controlling			Noncontrolling			Controlling			Noncontrolling
		Shareholders			Shareholders			Shareholders			Shareholders
	Basic and diluted net income per share:
	Net loss attributable to common stock	$	(47,896,411	)	$	(9,822,624	)	$	(77,840,649	)	$	(15,108,629	)
	Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(17,915,855	)		(3,674,194	)		—			—
	Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders		(11,986,242	)		(2,458,146	)		—			—
	Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders		—			—			12,488,175			(12,488,175	)
	Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders		—			—			(167,913,898	)		(32,591,568	)

	Undistributed net loss	$	(77,798,508	)	$	(15,954,964	)	$	(233,266,372	)	$	(60,188,372	)


	Basic and diluted weighted average number of common shares outstanding		170,645,985			34,996,177			171,573,632			33,301,911


	Basic and diluted net loss per common share	$	(0.46	)	$	(0.46	)	$	(1.36	)	$	(1.81	)

Restructuring_Expense_Tables

Restructuring Expense (Tables)	9 Months Ended
Restructuring Expense (Tables)	Sep. 30, 2013
Restructuring And Related Activities [Abstract]	'
Accrued Liability Associated with Restructuring Charges	'
	As of September 30, 2013, the accrued liability associated with the restructuring charges consisted of the following:


		Workforce			Excess			Total
		Reduction			Facilities			Total
	Accrued liability as of December 31, 2012	$	1,620,956		$	—		$	1,620,956
	Charges		—			99,004			99,004
	Payments		(1,451,450	)		(99,004	)		(1,550,454	)

	Accrued liability as of September 30, 2013	$	169,506		$	—		$	169,506

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Summary Of Significant Accounting Policies [Line Items]	'	'
Allowance for doubtful accounts receivable	$396,000	$1,200,000
Accounts receivable, net	9,975,784	13,130,387
Period of warranty on products	'5 years	'
Receivables Pledged as Collateral [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Accounts receivable, net	$8,200,000	$11,400,000

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Summary of Warranty Provision (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013
Regulatory Assets [Abstract]	'
Warranty provision, Beginning Balance	$2,108,012
Additions to provision	1,977,142
Less warranty costs	-2,653,091
Warranty provision, Ending Balance	$1,432,063

Liquidity_and_Capital_Resource1

Liquidity and Capital Resources - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2012

Dec. 31, 2011

Sep. 11, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 11, 2013

Sep. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Mar. 31, 2013

Series J Redeemable Convertible Preferred Stock [Member]

Holdings II [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Wells Fargo ABL [Member]

Wells Fargo ABL Amendment No. 6 [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Maximum [Member]

Liquidity And Capital Resources [Line Items]

Cash and cash equivalents

$10,292,524

$15,834,077

$20,535,127

$3,071,673

Restricted cash under asset-based revolving credit facility

5,000,000

Maximum borrowing capacity under credit facility

50,000,000

47,500,000

10,000,000

Maximum borrowing percentage of accounts receivable invoices

85.00%

Credit facility restricted cash and cash equivalents computation eligible inventory maximum

7,500,000

Description of Line of Credit with Wells Fargo ABL

'The Wells Fargo ABL provides the Company with a borrowing capacity of up to $50.0 million, which capacity is equal to the sum of (i) 85% of its eligible accounts receivable plus up to $7.5 million of eligible inventory, less certain reserves established against such accounts receivable and inventory by Wells Fargo from time to time pursuant to the Wells Fargo ABL, plus (ii) unrestricted cash held in a Wells Fargo deposit account (bQualified Cashb), plus (iii) the amount of the Second Lien Letter of Credit Facility with Ares Capital Corporation (bAres Capitalb), pledged in favor of Wells Fargo (the bAres Letter of Credit Facilityb) for the benefit of the Company (collectively, the bBorrowing Baseb). The Company is at all times required to maintain (i) a Borrowing Base that exceeds the amount of its outstanding borrowings under the Wells Fargo ABL by at least $5.0 million and (ii) $5.0 million in Qualified Cash. The Company would be required to comply with certain specified EBITDA requirements in the event that it has less than $2.0 million available for borrowing under the Wells Fargo ABL.

Required to maintain minimum excess of borrowing availability

5,000,000

Available borrowing with certain specified EBITDA Requirements less than

2,000,000

Maturity date of wells Fargo

2-Apr-14

Reduced credit available under the Wells Fargo ABL

2,500,000

Company's consolidated earnings (loss) before interest, tax, depreciation, and amortization

-20,200,000

Amount outstanding under credit facility

30,500,000

Remaining borrowing capacity

14,100,000

48,500,000

Issuance of preferred stock

17,394

12,500

2,500

2,394

Preferred stock, par value

$1,000

$0.00

Fair value per share

$1,000

Gross proceeds

$49,000,000

$67,100,000

$17,400,000

Sufficient capital to fund operations in term of months

'12 months

Detail_of_Certain_Balance_Shee2

Detail of Certain Balance Sheet Accounts - Schedule of Inventory (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]	'	'
Raw materials and components	$14,135,586	$15,150,768
Work-in-process	1,856,235	1,309,447
Finished goods	10,771,072	12,521,229
Total inventory, net	$26,762,893	$28,981,444

Detail_of_Certain_Balance_Shee3

Detail of Certain Balance Sheet Accounts - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Statement Of Financial Position [Abstract]	'	'	'	'	'
Inventory allowances	$19,700,000	'	$19,700,000	'	$25,600,000
Depreciation related to property and equipment	2,600,000	2,200,000	6,900,000	6,400,000	'
Impairment charges	'	$1,693,779	$1,328	$1,693,779	'

Detail_of_Certain_Balance_Shee4

Detail of Certain Balance Sheet Accounts - Schedule of Property and Equipment, Net (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	$30,443,257	$31,136,800
Accumulated depreciation	-20,335,836	-14,593,687
Total property and equipment, net	10,107,421	16,543,113
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	1,541,850	1,627,933
Office Furniture and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	1,180,563	1,255,244
Computer Hardware and Software [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	9,369,127	8,924,424
Tooling, Production and Test Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	18,225,025	19,194,959
Construction-in-process [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Total property and equipment	$126,692	$134,240

Intangible_Assets_Schedule_of_

Intangible Assets - Schedule of Intangible Assets (Detail) (Developed Technology Rights [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Indefinite-lived Intangible Assets [Line Items]	'	'
Cost, Less Impairment Charges	1,757,651	988,629
Accumulated Amortization	-147,700	-124,219
Net Book Value	1,609,951	864,410
Minimum [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Estimated Remaining Useful Life	'11 years	'11 years 7 months 6 days
Maximum [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Estimated Remaining Useful Life	'20 years	'20 years

Intangible_Assets_Summary_of_I

Intangible Assets - Summary of Impairment Charges (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	$379,537	'	$379,537
LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	380,000	'	'
Patents [Member] \| LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	15,984	'	'
Trademarks [Member] \| LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	19,541	'	'
License Agreements [Member] \| LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	44,923	'	'
Customer Relationships [Member] \| LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	$299,089	'	'

Intangible_Assets_Additional_I

Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
Intangible Assets - Additional Information (Detail) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Amortization expense of intangible assets	$12,000	$61,000	$27,000	$198,000
Total impairment charge	'	379,537	'	379,537
LSGBV [Member]	'	'	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Total impairment charge	'	$380,000	'	'

Lines_of_Credit_Additional_Inf

Lines of Credit - Additional Information (Detail) (USD $)	9 Months Ended
Lines of Credit - Additional Information (Detail) (USD $)	Sep. 30, 2013	Jun. 04, 2013	Mar. 31, 2013	Dec. 31, 2012
Credit Facilities [Line Items]	'	'	'	'
Accounts receivable, net	$9,975,784	'	'	$13,130,387
Inventories, net	26,762,893	'	'	28,981,444
Restricted cash	5,000,000	'	'	5,000,000
Wells Fargo ABL [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Maximum borrowing capacity under credit facility	50,000,000	'	'	'
Maximum borrowing percentage of accounts receivable invoices	85.00%	'	'	'
Line of credit facility, maximum borrowing of accounts receivable plus of eligible inventory less certain reserves	7,500,000	'	'	'
Amount outstanding under credit facility	30,500,000	'	'	1,500,000
Remaining borrowing capacity	14,100,000	'	'	48,500,000
Accounts receivable, net	8,200,000	'	'	'
Inventories, net	25,700,000	'	'	'
Cash	10,000,000	'	'	'
Interest rate on the Wells Fargo ABL	3.25%	'	'	'
Credit facility maturity date	2-Apr-14	'	'	'
Minimum excess borrowing availability	5,000,000	'	'	'
Restricted cash	5,000,000	'	'	'
Borrowing availability bench mark to comply with EDITDA requirements	2,000,000	'	'	'
Reduced credit available under the Wells Fargo ABL	2,500,000	'	2,500,000	'
Securities pledged as collateral	65.00%	'	'	'
Increased the Letter of Credit	'	7,000,000	'	'
Letter of Credit Limit	'	2,000,000	'	'
Wells Fargo ABL [Member] \| LIBOR [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	1.00%	'	'	'
Wells Fargo ABL [Member] \| Minimum [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Unused line fee percentage	0.38%	'	'	'
Termination fee	250,000	'	'	'
Wells Fargo ABL [Member] \| Maximum [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Unused line fee percentage	1.00%	'	'	'
Termination fee	500,000	'	'	'
Advances to certain affiliates	500,000	'	'	'
Advances to certain affiliates, Thereafter	250,000	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option One [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Interest rate added to base rate depending on credit availability	0.75%	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option One [Member] \| LIBOR [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	3.00%	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option Two [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Interest rate added to base rate depending on credit availability	1.25%	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option Two [Member] \| LIBOR [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	3.50%	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option Three [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Interest rate added to base rate depending on credit availability	1.75%	'	'	'
Wells Fargo ABL [Member] \| Interest Rate Option Three [Member] \| LIBOR [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	4.00%	'	'	'
Wells Fargo ABL [Member] \| Federal Fund Rate [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	0.50%	'	'	'
Wells Fargo ABL Amendment No. 6 [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Maximum borrowing capacity under credit facility	47,500,000	'	47,500,000	'
Company's consolidated earnings (loss) before interest, tax, depreciation, and amortization	-20,200,000	'	'	'
Wells Fargo ABL Amendment No. 6 [Member] \| Maximum [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Maximum borrowing capacity under credit facility	10,000,000	'	10,000,000	'
Ares Capital [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	0.50%	'	'	'
Interest rate added to base rate depending on credit availability	9.00%	'	'	'
Standby letter of credit	25,000,000	'	'	'
Annual administrative fee	$50,000	'	'	'
Quarterly fronting fee	0.75%	'	'	'
Quarterly letter of credit fee	10.00%	'	'	'
Issued and outstanding capital stock pledged	65.00%	'	'	'
Ares Capital [Member] \| Interest Rate Option One [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	1.00%	'	'	'
Ares Capital [Member] \| Interest Rate Option Two [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	1.50%	'	'	'
Ares Capital [Member] \| Interest Rate Option Three [Member]	'	'	'	'
Credit Facilities [Line Items]	'	'	'	'
Percentage added to base rate	10.00%	'	'	'

Fair_Value_Measurements_Compan

Fair Value Measurements - Company's Financial Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) (Fair Value Measurements [Member], USD $)	Sep. 30, 2013
Quoted Price in Active Markets for Identical Assets Level 1 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] \| Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] \| Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] \| September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Quoted Price in Active Markets for Identical Assets Level 1 [Member] \| Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Significant Other Observable Inputs Level 2 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Significant Other Observable Inputs Level 2 [Member] \| Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	'
Significant Other Observable Inputs Level 2 [Member] \| Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Significant Other Observable Inputs Level 2 [Member] \| September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Significant Other Observable Inputs Level 2 [Member] \| Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	'
Significant Unobservable Inputs Level 3 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	11,939,952
Significant Unobservable Inputs Level 3 [Member] \| Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets (Recurring)	1,600,000
Significant Unobservable Inputs Level 3 [Member] \| Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	6,639,952
Significant Unobservable Inputs Level 3 [Member] \| September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	1,600,000
Significant Unobservable Inputs Level 3 [Member] \| Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of assets and liabilities, Total	$3,700,000

Fair_Value_Measurements_Reconc

Fair Value Measurements - Reconciliation of the Beginning and Ending Balances for Assets and Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) (Significant Unobservable Inputs Level 3 [Member], USD $)	9 Months Ended
	Sep. 30, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Beginning balance	($7,960,705)
Realized and unrealized gains (losses) included in net loss	1,320,753
Purchases, sales, issuances and settlements	-3,700,000
Transfers in or out of Level 3	'
Ending balance	-10,339,952
Pegasus Commitment [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Beginning balance, December 31, 2012	1,360,000
Realized and unrealized gains (losses) included in net loss	240,000
Purchases, sales, issuances and settlements	'
Transfers in or out of Level 3	'
Ending balance, September 30, 2013	1,600,000
Riverwood Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Beginning balance	-7,960,705
Realized and unrealized gains (losses) included in net loss	1,320,753
Purchases, sales, issuances and settlements	'
Transfers in or out of Level 3	'
Ending balance	-6,639,952
September 2012 Warrants [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Beginning balance	-1,360,000
Realized and unrealized gains (losses) included in net loss	-240,000
Purchases, sales, issuances and settlements	'
Transfers in or out of Level 3	'
Ending balance	-1,600,000
Pegasus Warrant [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Beginning balance	'
Realized and unrealized gains (losses) included in net loss	'
Purchases, sales, issuances and settlements	-3,700,000
Transfers in or out of Level 3	'
Ending balance	($3,700,000)

Fair_Value_Measurements_Additi

Fair Value Measurements - Additional Information (Detail) (USD $)	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Assets measured on a non-recurring basis	$0
Liabilities measured on a non-recurring basis	$0

Series_J_Redeemable_Convertibl1

Series J Redeemable Convertible Preferred Stock - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

1 Months Ended

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Sep. 11, 2013

Sep. 30, 2013

Sep. 11, 2013

Sep. 30, 2013

Oct. 16, 2013

Sep. 11, 2013

Sep. 30, 2013

Sep. 11, 2013

Sep. 30, 2013

Pegasus Warrant [Member]

May 26, 2014 Prior [Member]

May 26, 2014 After [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Holdings II [Member]

PCA Holdings [Member]

Riverwood Holdings [Member]

Pegasus [Member]

Subsequent Event [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Pegasus Warrant [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Temporary Equity [Line Items]

Issuance of preferred stock

17,394

1,449

12,500

2,500

2,394

Shares purchased, per share value

$1,000

Gross proceeds

$49,000,000

$67,100,000

$17,400,000

Shares issued to Holdings II, in consideration for advisory services

10,000,000

Description of Series J Subscription Agreement

'Pursuant to the Series J Subscription Agreement, Pegasus committed to purchase the number of Preferred Shares equal to 20,000 minus the aggregate number of Series J Preferred Shares issued in the Series J Preferred Offering and the Preemptive Rights Offering at a price per share equal to the Stated Value (the "Pegasus Series J Commitment")

Preferred Shares sold

20,000

Aggregate gross proceeds

1,400,000

Purchase of Preferred Stock

1,157

Aggregate gross proceeds

1,200,000

Conversion price per share

$0.95

Number of times liquidation amount multiplied

1.75

Redemption value of Preferred Stock

21,600,000

Change in redemption value

Number of shares of common stock

42,614,646

10,000,000

Percentage of total equity

2.76%

Total equity value

523,900,000

Pegasus Warrant expiration date

25-May-22

Change in fair value of warrants

Series_H_and_Series_I_Redeemab1

Series H and Series I Redeemable Convertible Preferred Stock - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2012

Sep. 30, 2013

25-May-12

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 25, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Dec. 31, 2012

25-May-12

September 2012 Warrants [Member]

Pegasus Commitment [Member]

Riverwood Warrant [Member]

September2012 Warrant [Member]

Portman [Member]

Cleantech A [Member]

Cleantech B [Member]

RW LSG Management Holdings LLC [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series I Redeemable Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Issuance of preferred stock

113,643

49,000

60,705

62,365

6,364

Shares purchased, per share value

$1,000

$0.00

$1,000

$0.00

Gross proceeds

$49,000,000

$67,100,000

Right to purchase common stock

18,092,511

Number of common shares

208,144,318

205,558,486

4,000,000

3,406,041

593,959

Conversion price per share

$0.95

Initial conversion price per share

$1.18

Consolidated earnings before interest, taxes, depreciation and amortization

10,000,000

Increase in consolidated earnings before interest, taxes, depreciation and amortization

50,000,000

Deemed dividend

14,400,000

Change in redemption value

Warrant was issued to Riverwood Management

25-May-12

Right to purchase agreement of common stock

42,614,646

5,427,751

Exercise percent of warrants

5.00%

Equity value of company exceeds

523,900,000

Expiration date

25-May-22

Change in fair value of warrants

-2,100,000

2,400,000

1,300,000

2,700,000

Number of days available for redemption of shares

'10 days

Exercise price of common stock per share

$0.72

change in fair value of commitment shares

320,000

240,000

320,000

240,000

Change in fair value of warrants

Series_G_Preferred_Units_Addit

Series G Preferred Units - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Dec. 31, 2011

18-May-12

Mar. 28, 2012

Mar. 20, 2012

2-May-12

Apr. 02, 2012

Feb. 24, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2011

Sep. 30, 2013

31-May-12

Dec. 31, 2011

Holdings II [Member]

PCA Holdings [Member]

Leon Wagner [Member]

Series G Preferred Stock [Member]

November 17, 2012 [Member]

February 21, 2014 [Member]

PCA Holdings [Member]

Leon Wagner [Member]

Accredited Investors [Member]

Class of Stock [Line Items]

Number of aggregate Series G Preferred Units issued and outstanding

52,358

Issue price per Series G Preferred Unit

$1,000

Consideration from Preferred Units issued

$52,400,000

Preferred units purchased

14,958

2,000

1,000

2,000

17,650

6,500

13,250

Accretion of preferred stock

7,523,459

7,500,000

Gross proceeds

49,000,000

67,100,000

50,000,000

Shares purchased, per share value

$1,000

$0.00

$1,000

Initial annual cumulative dividend

6.00%

10.00%

15.00%

18.00%

Dividend preferred stock

$21,590,049

$202,105,466

$1,800,000

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Mar. 22, 2013

Jan. 02, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2012

Aug. 31, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

25-May-12

Sep. 30, 2011

Jan. 13, 2011

Sep. 30, 2013

Subsequent Event [Member]

Minimum [Member]

Maximum [Member]

September 2012 Warrants [Member]

Restricted Stock [Member]

Stock Options [Member]

THD Warrant [Member]

Chief Executive Officer [Member]

Minimum [Member]

Maximum [Member]

Class of Stock [Line Items]

Expenses related to stock options issued

$238,000

$302,000

$238,000

$966,000

$49,000

$119,000

$11,000

$20,000

$129,000

Shares issued for compensation package

192,308

500,000

Common stock, shares outstanding

208,144,318

205,558,486

5,000,000

Common stock, Purchase price

Strategic Purchasing Agreement date with the home depot to supply LED retrofit lamps and fixtures

23-Jul-10

Base date to exercise price of warrant

23-Jul-10

Common stock vested shares

1,000,000

Percentage of gross product order

20.00%

Vesting date of warrants

31-Dec-14

31-Dec-15

Long- term purchase commitment additional extension time period, years

'1 year

'3 years

Long- term purchase commitment, time period, years

'3 years

Per share of common stock

$1.95

Common stock exercisable warrants

42,614,646

5,000,000

Number of exercisable shares of common stock

5,123,715

Shares issuable pursuant to warrant vested

2,049,486

Shares remain subject to vesting

3,074,229

Total equity value of company

523,900,000

Warrant exercisable date

9-Oct-15

Revenue (increase) reduction

$9,000

($257,000)

$23,000

$458,000

Stockholders_Equity_Schedule_o

Stockholders' Equity - Schedule of Warrants for Purchase of Common Stock (Detail)

Sep. 30, 2013

Sep. 11, 2013

Sep. 30, 2013

Pegasus Warrant [Member]

RW LSG Management Holdings LLC [Member]

Certain Other Investors [Member]

Cleantech Europe II (A) LP [Member]

Cleantech Europe II (B) LP [Member]

Portman Limited [Member]

Aquillian Investments LLC [Member]

Pegasus [Member]

Investors in Rights Offering [Member]

The Home Depot [Member]

Riverwood Warrants [Member]

September 2012 Warrants [Member]

Private Placement Series H [Member]

Pegasus Warrant [Member]

Series D Warrants [Member]

Purchasing Agreement [Member]

Minimum [Member]

Maximum [Member]

Class of Warrant or Right [Line Items]

Number of common shares

42,614,646

10,000,000

5,427,751

12,664,760

5,427,751

3,406,041

593,959

4,000,000

830,508

10,000,000

567,912

5,123,715

Exercise Price

0.72

1.18

5.57

5.59

1.95

Exercise Price, Description

'Variable

Expiration Date, period start

'March 3, 2022

'2014

Expiration Date, period end

'May 25, 2022

'September 25, 2022

'September 25, 2017

'May 25, 2022

'April 19, 2022

'2018

Earnings_Loss_Per_Share_Additi

Earnings (Loss) Per Share - Additional Information (Detail)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]	'	'	'	'
Method used to compute net loss per share of noncontrolling shareholders and controlling shareholders common stock	'	'	'two-class method	'two-class method
Common stock equivalents outstanding	190.4	111.1	186.8	53

Earnings_Loss_Per_Share_Comput

Earnings (Loss) Per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Basic and diluted net income per share:	'	'	'	'
Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders	'	'	($14,400,000)	'
Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders	'	'	'	-1,799,392
Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders	'	'	-21,590,049	-202,105,466
Controlling Shareholders [Member]	'	'	'	'
Basic and diluted net income per share:	'	'	'	'
Net loss attributable to common stock	-21,156,773	-19,990,435	-47,896,411	-77,840,649
Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders	-11,982,712	'	-11,986,242	'
Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders	'	'	'	12,488,175
Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders	'	-43,320,722	'	-167,913,898
Undistributed net loss	-51,050,064	-63,311,157	-77,798,508	-233,266,372
Basic and diluted weighted average number of common shares outstanding	170,672,339	170,560,715	170,645,985	171,573,632
Basic and diluted net loss per common share	($0.30)	($0.37)	($0.46)	($1.36)
Controlling Shareholders [Member] \| Series J Redeemable Convertible Preferred Stock [Member]	'	'	'	'
Basic and diluted net income per share:	'	'	'	'
Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders	-17,910,579	'	-17,915,855	'
Noncontrolling Shareholders [Member]	'	'	'	'
Basic and diluted net income per share:	'	'	'	'
Net loss attributable to common stock	-4,346,354	-4,005,071	-9,822,624	-15,108,629
Deemed dividends due to change in Series H and Series I Preferred Stock conversion price attributable to all shareholders	-2,461,676	'	-2,458,146	'
Deemed dividends related to the Repurchase Obligation on common stock attributable to controlling shareholders	'	'	'	-12,488,175
Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders	'	-8,679,278	'	-32,591,568
Undistributed net loss	-10,487,500	-12,684,349	-15,954,964	-60,188,372
Basic and diluted weighted average number of common shares outstanding	35,062,174	34,171,729	34,996,177	33,301,911
Basic and diluted net loss per common share	($0.30)	($0.37)	($0.46)	($1.81)
Noncontrolling Shareholders [Member] \| Series J Redeemable Convertible Preferred Stock [Member]	'	'	'	'
Basic and diluted net income per share:	'	'	'	'
Deemed dividends related to the Series H and I Preferred Stock attributable to all shareholders	($3,679,470)	'	($3,674,194)	'

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

Sep. 25, 2012

25-May-12

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 11, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

25-May-12

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

2-May-12

Apr. 02, 2012

Feb. 24, 2012

Dec. 31, 2011

18-May-12

Mar. 28, 2012

Mar. 20, 2012

18-May-12

Mar. 20, 2012

Mar. 28, 2012

31-May-12

Sep. 11, 2013

Apr. 13, 2012

Dec. 31, 2011

Sep. 11, 2013

Sep. 30, 2013

Series H Redeemable Convertible Preferred Stock [Member]

Series G Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

2012 Support Services Agreement [Member]

Zouk Support Services Agreement [Member]

Riverwood Support Services Agreement [Member]

Pegasus Capital [Member]

LSGC Holdings [Member]

GYRO LLC [Member]

T&M Protection Resources [Member]

MWW Group [Member]

Leon Wagner [Member]

PCA Holdings [Member]

Holdings II [Member]

Riverwood Holdings [Member]

Pegasus [Member]

Series H Redeemable Convertible Preferred Stock [Member]

Series G Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Series G Preferred Stock [Member]

Series J Redeemable Convertible Preferred Stock [Member]

Maximum [Member]

Related Party Transaction Due From To Related Party [Line Items]

Due to related parties

$125,000

$100,000

$20,000

$187,500

Related party transaction payment due for support services

125,000

Ownership percentage of subsidiary held in parent

82.20%

Services agreement, expiration terms

'The 2012 Support Services Agreement expires upon the earlier of: (i) June 30, 2017; (ii) a Change of Control or (iii) a QPO. During the first 30 days of any calendar quarter, the Company has the right to terminate the 2012 Support Services Agreement, effective immediately upon written notice to Pegasus Capital. Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Companybs largest stockholders and beneficially owned approximately 82.2% of the Companybs common stock as of September 30, 2013.

'The Zouk Support Services Agreement expires upon the earlier of (i) September 25, 2022; (ii) such date that Zouk and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the September 2012 Preferred Offering, on an as-converted basis; (iii) such date that the Company and Zouk may mutually agree in writing; (iv) a Change of Control and (v) a QPO.

'The Riverwood Support Services Agreement with Riverwood Holdings, pursuant to which the Company agreed to pay Riverwood Holdings $20,000 for the period from May 25, 2012 through June 30, 2012 and thereafter $50,000 for each calendar quarter beginning on July 1, 2012, in exchange for certain support services during such periods. The Riverwood Support Services Agreement expires upon the earlier of: (i) May 25, 2022, (ii) such date that Riverwood Management and/or its affiliates directly or indirectly beneficially own less than 37.5% of the shares of Series H Preferred Stock purchased pursuant to the Preferred Offering, on an as-converted basis (together with any shares of common stock issued upon conversion thereof); (iii) such date that the Company and Riverwood may mutually agree in writing (iv) a Change of Control or (v) a QPO. In addition, the Company has brought in several employees of Riverwood to provide consulting services, including Brad Knight, who served as the Companybs Chief Operations Officer until July 8, 2013 and now leads the transition of our manufacturing operations to our contract manufacturer in Asia. During the three and nine months ended September 30, 2013, the Company incurred $ and $ million, respectively, of consulting fees for services provided by Riverwood, included in selling, distribution and administrative expense. During the three and nine months ended September 30, 2012, the Company incurred $387,000 and $648,000, respectively, of consulting fees for services provided by Riverwood, included in selling, distribution and administrative expense.

Letter agreement entering date

17-Jan-12

Related party interest expense

250,000

Related party expense

250,000

16,000

118,000

17,000

15,000

40,000

148,000

Percentage of shares owned in preferred stock

37.50%

Future Payment to Riverwood Holdings

50,000

Related party service consulting fees

656,000

387,000

1,700,000

648,000

Issuance of preferred stock

17,394

2,500

12,500

2,394

Gross proceeds

49,000,000

67,100,000

50,000,000

17,400,000

Shares issued to Holdings II, in consideration for advisory services

10,000,000

Shares purchased

1,157

Gross proceeds

1,200,000

Preferred units sold

2,000

1,000

2,000

6,500

2,000

17,650

2,000

14,958

Proceeds from sale of series G preferred units

$85,205,000

$17,394,000

$5,000,000

$6,000,000

$2,000,000

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk - Additional Information (Detail)	3 Months Ended		9 Months Ended			12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Dec. 31, 2012
	Customer	Customer	Customer	Customer	Accounts Receivable [Member]	Accounts Receivable [Member]
					Customer	Customer
Concentration Risk [Line Items]	'	'	'	'	'	'
Percentage of revenue represented by major customers	56.00%	67.00%	52.00%	72.00%	'	'
Concentration Risk, Percentage	'	'	'	'	60.00%	77.00%
Number of customers	1	2	1	2	1	2

Restructuring_Expense_Addition

Restructuring Expense - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Expense related to the termination of the lease on the Mexico manufacturing facility	$99,000	$2,200,000	$99,000	$4,100,000
Restructuring Charges	55,275	3,908,562	184,107	5,759,814
Remaining accrual	'	'	170,000	'
Mexico Closing [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
No of employees terminated	'	'	520	'
Number of employee not yet terminated	'	'	1	'
Costs incurred or accrued in the last quarter	'	'	400,000	'
Mexico Closing [Member] \| Workforce Reduction [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Restructuring accrued expenses and charges	'	1,700,000	'	1,700,000
Mexico Closing [Member] \| Non-cash Impairment [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Restructuring accrued expenses and charges	'	$1,700,000	'	$1,700,000
UNITED STATES	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Reduction in full time headcount	'	'	10	'

Restructuring_Expense_Accrued_

Restructuring Expense - Accrued Liability Associated with the Restructuring Charges (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013
Restructuring Cost and Reserve [Line Items]	'
Accrued liability, Beginning Balance	$1,620,956
Charges	99,004
Payments	-1,550,454
Accrued liability, Ending Balance	169,506
Workforce Reduction [Member]	'
Restructuring Cost and Reserve [Line Items]	'
Accrued liability, Beginning Balance	1,620,956
Charges	'
Payments	-1,451,450
Accrued liability, Ending Balance	169,506
Excess Facilities [Member]	'
Restructuring Cost and Reserve [Line Items]	'
Accrued liability, Beginning Balance	'
Charges	99,004
Payments	-99,004
Accrued liability, Ending Balance	'

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013
	Claim
	Employees
Contingencies And Commitments [Line Items]	'
Number of employee defendants in lawsuit	2
Number of new claims	3
Estimated possible loss	$300,000
Geveran Investments Ltd. [Member]	'
Contingencies And Commitments [Line Items]	'
Investment in the company, as well as recovery of costs and attorney's fees	25,000,000
LSGBV [Member]	'
Contingencies And Commitments [Line Items]	'
Investment in the company, as well as recovery of costs and attorney's fees	$1,200,000